SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    0 A number of dramatic breakthroughs in the neurobiology of addiction have occurred in the past 40 years .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    0 A_ZZ1 number_NN1 of_IO dramatic_JJ breakthroughs_NN2 in_II the_AT neurobiology_NN1 of_IO addiction_NN1 have_VH0 occurred_VVN in_II the_AT past_JJ 40_MC years_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    1 Two domains will be highlighted : the neurocircuitry of addiction and the molecular biology of addiction targets .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    1 Two_MC domains_NN2 will_VM be_VBI highlighted_VVN :_Y the_AT neurocircuitry_NN1 of_IO addiction_NN1 and_CC the_AT molecular_JJ biology_NN1 of_IO addiction_NN1 targets_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    2 The neurebiological substrates for the reinforcing effects of drugs of abuse have been largely identified both at the initial site of action and in the circuitry involved .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    2 The_AT neurebiological_JJ substrates_NN2 for_IF the_AT reinforcing_JJ@ effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 have_VH0 been_VBN largely_RR identified_VVN both_RR at_II the_AT initial_JJ_NN1 site_NN1 of_IO action_NN1 and_CC in_II the_AT circuitry_NN1 involved_VVD_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    3 In human imaging studies , decreases in dopaminergic function have been identified as a key element of addiction , /ending support for research on the role of dopamine in addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    3 In_II human_JJ_NN1 imaging_NN1_VVG studies_NN2 ,_Y decreases_VVZ in_II dopaminergic_JJ function_NN1 have_VH0 been_VBN identified_VVN as_II a_AT1 key_JJ element_NN1 of_IO addiction_NN1 ,_Y /ending_JJ_NN1 support_NN1 for_IF research_NN1 on_II the_AT role_NN1 of_IO dopamine_NN1 in_II addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    4 Three novel areas currently are emerging : the role of deficits in frontal cortex functioning , changes in the brain neurocircuitry that convey long-term vulnerability to relapse , and the role of nondopaminergic systems in the neuroadaptations associated with the development of drug dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    4 Three_MC novel_JJ areas_NN2 currently_RR are_VBR emerging_VVG_JJ :_Y the_AT role_NN1 of_IO deficits_NN2 in_II frontal_JJ cortex_NN1 functioning_VVG_NN1@ ,_Y changes_NN2_VVZ@ in_II the_AT brain_NN1 neurocircuitry_NN1 that_CST convey_VV0 long-term_JJ vulnerability_NN1 to_TO relapse_VVI ,_Y and_CC the_AT role_NN1 of_IO nondopaminergic_JJ systems_NN2 in_II the_AT neuroadaptations_NN2 associated_VVN with_IW the_AT development_NN1 of_IO drug_NN1 dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    5 Parallel to these functional changes have been major advances in our understanding of the molecular biology of addiction ; the greatest contribution has been in the understanding of the molecular mechanisms of opioid action .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    5 Parallel_RR_NN1_VV0@ to_II these_DD2 functional_JJ changes_NN2 have_VH0 been_VBN major_JJ advances_NN2 in_II our_APPGE understanding_NN1 of_IO the_AT molecular_JJ biology_NN1 of_IO addiction_NN1 ;_Y the_AT greatest_JJT contribution_NN1 has_VHZ been_VBN in_II the_AT understanding_NN1 of_IO the_AT molecular_JJ mechanisms_NN2 of_IO opioid_JJ_NN1 action_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    6 This paper reviews the major developments in our understanding of the molecular biology to advance our knowledge of the function and regulation of opioid receptors and endorphins .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    6 This_DD1 paper_NN1 reviews_VVZ the_AT major_JJ developments_NN2 in_II our_APPGE understanding_NN1 of_IO the_AT molecular_JJ biology_NN1 to_TO advance_VVI our_APPGE knowledge_NN1 of_IO the_AT function_NN1 and_CC regulation_NN1 of_IO opioid_JJ_NN1 receptors_NN2 and_CC endorphins_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    7 <p> A number of dramatic breakthroughs in the neurobiology of addiction have occurred in the past 40 years with the support of the National Institute on Drug Abuse ( NIDA ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    7 <p>_Y A_AT1 number_NN1 of_IO dramatic_JJ breakthroughs_NN2 in_II the_AT neurobiology_NN1 of_IO addiction_NN1 have_VH0 occurred_VVN in_II the_AT past_JJ 40_MC years_NNT2 with_IW the_AT support_NN1 of_IO the_AT National_JJ Institute_NN1 on_II Drug_NN1 Abuse_NN1 (_Y NIDA_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    8 Two domains will be highlighted here : the neurocircuitry of addiction and the molecular biology of addiction targets .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    8 Two_MC domains_NN2 will_VM be_VBI highlighted_VVN here_RL :_Y the_AT neurocircuitry_NN1 of_IO addiction_NN1 and_CC the_AT molecular_JJ biology_NN1 of_IO addiction_NN1 targets_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0    9 Advances m several areas have dominated the field in the neurocircuitry of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0    9 Advances_NN2_VVZ m_MC@_ZZ1 several_DA2 areas_NN2 have_VH0 dominated_VVN the_AT field_NN1 in_II the_AT neurocircuitry_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   10 Behaviorists in the United States laid the groundwork for the development of the animal models of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   10 Behaviorists_NN2_NP1@ in_II the_AT United_NP1 States_NP1 laid_VVD the_AT groundwork_NN1 for_IF the_AT development_NN1 of_IO the_AT animal_NN1 models_NN2 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   11 The neurobiological substrates for the reinforcing effects of drugs of abuse have been largely identified both at the initial site of action ( receptor , reuptake site , etc. ) as well as the circuitry involved ( mesocorticolimbic dopamine system and endogenous opioid systems ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   11 The_AT neurobiological_JJ substrates_NN2 for_IF the_AT reinforcing_JJ@ effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 have_VH0 been_VBN largely_RR identified_VVN both_RR at_II the_AT initial_JJ_NN1 site_NN1 of_IO action_NN1 (_Y receptor_NN1 ,_Y reuptake_VV0_NN1 site_NN1 ,_Y etc._RA )_Y as_II31 well_II32 as_II33 the_AT circuitry_NN1 involved_VVN_VVD (_Y mesocorticolimbic_JJ dopamine_NN1 system_NN1 and_CC endogenous_JJ opioid_JJ_NN1 systems_NN2 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   12 In human imaging studies , decreases in dopaminergic function have been identified as a key common element of addiction , lending support to what became a strong program on the role of dopamine in addiction ( Volkow Fowler , 2000 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   12 In_II human_JJ_NN1 imaging_NN1_VVG studies_NN2 ,_Y decreases_VVZ in_II dopaminergic_JJ function_NN1 have_VH0 been_VBN identified_VVN as_II a_AT1 key_JJ common_JJ element_NN1 of_IO addiction_NN1 ,_Y lending_VVG_NN1 support_NN1_VV0 to_II what_DDQ became_VVD a_AT1 strong_JJ program_NN1 on_II the_AT role_NN1 of_IO dopamine_NN1 in_II addiction_NN1 (_Y Volkow_NP1 Fowler_NP1 ,_Y 2000_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   13 <p> However , as emerging .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   13 <p>_Y However_RR ,_Y as_CSA emerging_VVG_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   14 The role of deficits in frontal cortex functioning has become an area of intense investigation .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   14 The_AT role_NN1 of_IO deficits_NN2 in_II frontal_JJ cortex_NN1 functioning_NN1@ has_VHZ become_VVN@ an_AT1 area_NN1 of_IO intense_JJ investigation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   15 The changes in the brain neurocircuitry that convey long-term vulnerability to relapse are being studied .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   15 The_AT changes_NN2 in_II the_AT brain_NN1 neurocircuitry_NN1 that_CST convey_VV0 long-term_JJ vulnerability_NN1 to_TO relapse_VVI are_VBR being_VBG studied_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   16 The role of nondopaminergic systems in the neuroadaptations associated with the development of drug dependence has also moved to the forefront .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   16 The_AT role_NN1 of_IO nondopaminergic_JJ systems_NN2 in_II the_AT neuroadaptations_NN2 associated_VVN with_IW the_AT development_NN1 of_IO drug_NN1 dependence_NN1 has_VHZ also_RR moved_VVN to_II the_AT forefront_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   17 <p> Parallel to these functional changes in the neurobiology of addiction have been major advances in our understanding of the molecular biology of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   17 <p>_Y Parallel_RR_NN1_VV0@ to_II these_DD2 functional_JJ changes_NN2 in_II the_AT neurobiology_NN1 of_IO addiction_NN1 have_VH0 been_VBN major_JJ advances_NN2 in_II our_APPGE understanding_NN1 of_IO the_AT molecular_JJ biology_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   18 Perhaps one of the greatest contributions has been in the understanding of the molecular mechanisms of opioid action .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   18 Perhaps_RR one_MC1 of_IO the_AT greatest_JJT contributions_NN2 has_VHZ been_VBN in_II the_AT understanding_NN1 of_IO the_AT molecular_JJ mechanisms_NN2 of_IO opioid_JJ_NN1 action_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   19 Dr. Simon 's contribution to these reflections will be to review some of the major developments ( " breakthroughs " ) in our understanding of the molecular biology and biochemistry of opiate action and the endogenous opioid system .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   19 Dr._NNB Simon_NP1 's_GE contribution_NN1 to_II these_DD2 reflections_NN2 will_VM be_VBI to_TO review_VVI some_DD of_IO the_AT major_JJ developments_NN2 (_Y "_Y breakthroughs_NN2 "_Y )_Y in_II our_APPGE understanding_NN1 of_IO the_AT molecular_JJ biology_NN1 and_CC biochemistry_NN1 of_IO opiate_NN1 action_NN1 and_CC the_AT endogenous_JJ opioid_JJ_NN1 system_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   20 Clearly , the list of breakthroughs discussed is not exhaustive , and the topics chosen are those deemed most important by Dr. Simon and within his areas of interest and expertise .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   20 Clearly_RR ,_Y the_AT list_NN1 of_IO breakthroughs_NN2 discussed_VVN is_VBZ not_XX exhaustive_JJ ,_Y and_CC the_AT topics_NN2 chosen_VVN are_VBR those_DD2 deemed_VVN most_DAT_RGT important_JJ by_II Dr._NNB Simon_NP1 and_CC within_II his_APPGE areas_NN2 of_IO interest_NN1 and_CC expertise_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   21 <p> L : CONCEPTUAL FRAMEWORK FOR ADDICTION Drug addiction , or substance dependence , is a chronically relapsing disorder characterized the drug , ( b ) loss of control in limiting intake , and ( c ) emergence of a negative emotional state ( e.g. , dysphoria , anxiety , irritability ) when access to the drug is prevented .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   21 <p>_Y L_ZZ1_NP1@ :_Y CONCEPTUAL_JJ FRAMEWORK_NN1 FOR_IF ADDICTION_NPX Drug_NN1 addiction_NN1 ,_Y or_CC substance_NN1 dependence_NN1 ,_Y is_VBZ a_AT1 chronically_RR relapsing_VVG_JJ@ disorder_NN1 characterized_VVN the_AT drug_NN1 ,_Y (_Y b_ZZ1 )_Y loss_NN1 of_IO control_NN1 in_II limiting_JJ_VVG intake_NN1 ,_Y and_CC (_Y c_ZZ1 )_Y emergence_NN1 of_IO a_AT1 negative_JJ emotional_JJ state_NN1 (_Y e.g._REX ,_Y dysphoria_NN1 ,_Y anxiety_NN1 ,_Y irritability_NN1 )_Y when_RRQ_CS access_NN1 to_II the_AT drug_NN1 is_VBZ prevented_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   22 Clinically , the occasional but limited use of an abusable drug is distinct from escalated drug use and the emergence of chronic drug dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   22 Clinically_RR_NP1@ ,_Y the_AT occasional_JJ but_CCB limited_JJ use_NN1 of_IO an_AT1 abusable_JJ drug_NN1 is_VBZ distinct_JJ from_II escalated_JJ% drug_NN1 use_NN1 and_CC the_AT emergence_NN1 of_IO chronic_JJ drug_NN1 dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   23 An important goal of current neurobiological research is to understand the neuropharmacological and neuroadaptive mechanisms within specific neurocircuits that mediate the transition from occasional , controlled drug use and the loss of behavioral control over drug-seeking , and drug-taking that defines chronic addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   23 An_AT1 important_JJ goal_NN1 of_IO current_JJ neurobiological_JJ research_NN1 is_VBZ to_TO understand_VVI the_AT neuropharmacological_JJ and_CC neuroadaptive_JJ mechanisms_NN2 within_II specific_JJ neurocircuits_NN2 that_CST mediate_VV0 the_AT transition_NN1 from_II occasional_JJ ,_Y controlled_VVD_JJ@_VVN drug_NN1 use_NN1 and_CC the_AT loss_NN1 of_IO behavioral_JJ_NN1 control_NN1 over_II drug-seeking_NN1_JJ ,_Y and_CC drug-taking_NN1 that_CST_DD1 defines_VVZ chronic_JJ addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   24 Drug addiction has been conceptualized as a disorder that moves from impulsivity to compulsivity in a collapsed cycle of addiction comprised of three stages : **26;5744;TOOLONG , binge intoxication , and withdrawal/ negative affect ( Figure 1 ; Koob , 2004 ; Koob , Sanna , Bloom , 1998 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   24 Drug_NN1 addiction_NN1 has_VHZ been_VBN conceptualized_VVN@ as_II a_AT1 disorder_NN1 that_CST_DD1 moves_VVZ_NN2 from_II impulsivity_NN1 to_II compulsivity_NN1 in_II a_AT1 collapsed_JJ% cycle_NN1 of_IO addiction_NN1 comprised_VVN of_IO three_MC stages_NN2 :_Y **26;5744;TOOLONG_FO ,_Y binge_VV0_NN1 intoxication_NN1 ,_Y and_CC withdrawal/_NN1 negative_JJ_NN1@ affect_NN1 (_Y Figure_NN1 1_MC1 ;_Y Koob_NP1 ,_Y 2004_MC ;_Y Koob_NP1 ,_Y Sanna_NP1 ,_Y Bloom_NP1 ,_Y 1998_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   25 <p> Multiple sources of reinforcement can be identified in these three stages ( Koob Le Moal , 2001 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   25 <p>_Y Multiple_JJ_NN1 sources_NN2 of_IO reinforcement_NN1 can_VM be_VBI identified_VVN in_II these_DD2 three_MC stages_NN2 (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2001_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   26 These include the positive reinforcement of the binge intoxication a negative emotional state ( e.g. , dysphoria , anxiety , and irritability ) that emerges when access to the drug is prevented during the withdrawal/negative affect stage , and the conditioned reinforcement associated with the **26;5772;TOOLONG ( craving ) stage ( Koob Le Moal , 2001 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   26 These_DD2 include_VV0 the_AT positive_JJ reinforcement_NN1 of_IO the_AT binge_NN1 intoxication_NN1 a_AT1 negative_JJ emotional_JJ state_NN1 (_Y e.g._REX ,_Y dysphoria_NN1 ,_Y anxiety_NN1 ,_Y and_CC irritability_NN1 )_Y that_CST_DD1 emerges_VVZ when_RRQ_CS access_NN1 to_II the_AT drug_NN1 is_VBZ prevented_VVN during_II the_AT withdrawal/negative_NN1 affect_NN1_VV0 stage_NN1 ,_Y and_CC the_AT conditioned_JJ reinforcement_NN1 associated_VVN with_IW the_AT **26;5772;TOOLONG_FO (_Y craving_VVG_NN1@ )_Y stage_NN1 (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2001_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   27 We will explore the neurobiological mechanisms of addiction involved in these stages of the addiction cycle , and how research has progressed from a focus on the neurochemical changes associated with the acute reinforcing effects of drugs of abuse to understanding the neuroadaptative changes that occur during the transition from taking drugs to addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   27 We_PPIS2 will_VM explore_VVI the_AT neurobiological_JJ mechanisms_NN2 of_IO addiction_NN1 involved_JJ in_II these_DD2 stages_NN2 of_IO the_AT addiction_NN1 cycle_NN1 ,_Y and_CC how_RRQ research_NN1 has_VHZ progressed_VVN from_II a_AT1 focus_NN1 on_II the_AT neurochemical_JJ changes_NN2 associated_VVN with_IW the_AT acute_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 to_II understanding_VVG the_AT neuroadaptative_JJ changes_NN2 that_CST occur_VV0 during_II the_AT transition_NN1 from_II taking_VVG drugs_NN2 to_II addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   28 A parallel evolution has been the exploration of first the neurocircuitry changes , and then the molecular changes , responsible for the neuroadaptations that mediate the development of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   28 A_AT1_ZZ1 parallel_JJ_NN1 evolution_NN1 has_VHZ been_VBN the_AT exploration_NN1 of_IO first_MD the_AT neurocircuitry_NN1 changes_NN2 ,_Y and_CC then_RT the_AT molecular_JJ changes_NN2 ,_Y responsible_JJ for_IF the_AT neuroadaptations_NN2 that_CST mediate_VV0 the_AT development_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   29 <p> L : ANIMAL MODELS OF DRUG ABUSE AND DEPENDENCE Much of the recent progress in understanding the mechanisms of addiction has derived from the study of animal models of addiction on specific drugs such as opiates , stimulants , and alcohol ( Shippenberg Koob , 2002 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   29 <p>_Y L_ZZ1_NP1@ :_Y ANIMAL_NN1 MODELS_NN2 OF_IO DRUG_NN1 ABUSE_NN1 AND_CC DEPENDENCE_NN1 Much_DA1_RR of_IO the_AT recent_JJ progress_NN1 in_II understanding_VVG the_AT mechanisms_NN2 of_IO addiction_NN1 has_VHZ derived_VVN from_II the_AT study_NN1 of_IO animal_NN1 models_NN2 of_IO addiction_NN1 on_II specific_JJ drugs_NN2 such_II21 as_II22 opiates_NN2 ,_Y stimulants_NN2 ,_Y and_CC alcohol_NN1 (_Y Shippenberg_NP1 Koob_NP1 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   30 While no animal model of addiction investigation of specific elements of the process of drug addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   30 While_CS no_AT animal_NN1 model_NN1 of_IO addiction_NN1 investigation_NN1 of_IO specific_JJ elements_NN2 of_IO the_AT process_NN1 of_IO drug_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   31 Such elements can be defined by models of different systems , models of psychological constructs , such as positive and negative reinforcement , and models of different stages of the addiction cycle Initially , animal models of addiction focused on the synaptic sites and transductive mechanisms ( how these sites convey changes m excitability ) m the nervous system on which drugs act initially to produce their positive reinforcing effects .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   31 Such_DA elements_NN2 can_VM be_VBI defined_VVN by_II models_NN2 of_IO different_JJ systems_NN2 ,_Y models_NN2 of_IO psychological_JJ constructs_NN2 ,_Y such_II21 as_II22 positive_JJ and_CC negative_JJ reinforcement_NN1 ,_Y and_CC models_NN2 of_IO different_JJ stages_NN2 of_IO the_AT addiction_NN1 cycle_NN1 Initially_RR ,_Y animal_NN1 models_NN2 of_IO addiction_NN1 focused_VVN_VVD on_II the_AT synaptic_JJ sites_NN2 and_CC transductive_JJ mechanisms_NN2 (_Y how_RRQ these_DD2 sites_NN2 convey_VV0 changes_NN2 m_ZZ1 excitability_NN1 )_Y m_ZZ1_MC@ the_AT nervous_JJ system_NN1 on_II which_DDQ drugs_NN2 act_VV0 initially_RR to_TO produce_VVI their_APPGE positive_JJ reinforcing_JJ@_VVG effects_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   32 Well-validated animal models exist for the positive reinforcing effects of drugs of abuse with high predictive validity .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   32 Well-validated_JJ animal_NN1 models_NN2 exist_VV0 for_IF the_AT positive_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 with_IW high_JJ predictive_JJ validity_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   33 Drugs self-administered by animals correspond well with those with high abuse potential in humans , and intravenous drug self-administration is considered an animal model predictive of abuse potential .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   33 Drugs_NN2 self-administered_NN1_JJ by_II animals_NN2 correspond_VV0 well_RR with_IW those_DD2 with_IW high_JJ abuse_NN1 potential_NN1 in_II humans_NN2 ,_Y and_CC intravenous_JJ drug_NN1 self-administration_NN1 is_VBZ considered_VVN an_AT1 animal_NN1 model_NN1 predictive_JJ of_IO abuse_NN1 potential_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   34 Other validated measures of the acute rewarding effects of drugs of abuse : include brain stimulation reward and conditioned place preference .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   34 Other_JJ validated_JJ@ measures_NN2 of_IO the_AT acute_JJ rewarding_JJ effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 :_Y include_VV0 brain_NN1 stimulation_NN1 reward_NN1 and_CC conditioned_JJ place_NN1 preference_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   35 <p> Animal models of components of the negative reinforcing effects of dependence have subsequently been developed , and animal models of craving are being used to explore how the nervous system adapts to drug use .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   35 <p>_Y Animal_NN1 models_NN2 of_IO components_NN2 of_IO the_AT negative_JJ_NN1@ reinforcing_JJ@_VVG effects_NN2 of_IO dependence_NN1 have_VH0 subsequently_RR been_VBN developed_VVN ,_Y and_CC animal_NN1 models_NN2 of_IO craving_VVG_NN1@ are_VBR being_VBG used_VVN to_TO explore_VVI how_RRQ the_AT nervous_JJ system_NN1 adapts_VVZ to_II drug_NN1 use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   36 Measures of the negative access to the drug is provided or the animals are made dependent with chronic exposure .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   36 Measures_NN2 of_IO the_AT negative_JJ access_NN1 to_II the_AT drug_NN1 is_VBZ provided_VVN or_CC the_AT animals_NN2 are_VBR made_VVN dependent_JJ_NN1@ with_IW chronic_JJ exposure_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   37 Dependent animals increase the amount of drug self-administration , increase the motivation to take drugs , and show an increase in drug seeking .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   37 Dependent_JJ animals_NN2 increase_VV0 the_AT amount_NN1 of_IO drug_NN1 self-administration_NN1 ,_Y increase_VV0 the_AT motivation_NN1 to_TO take_VVI drugs_NN2 ,_Y and_CC show_VVI an_AT1 increase_NN1 in_II drug_NN1 seeking_VVG_NN1@ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   38 These models provide validity model for compulsive drug use that characterizes the withdrawal/negative affect stage of the addiction cycle and the transition to addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   38 These_DD2 models_NN2 provide_VV0 validity_NN1 model_NN1 for_IF compulsive_JJ drug_NN1 use_VV0_NN1 that_CST_DD1 characterizes_VVZ the_AT withdrawal/negative_NN1 affect_NN1_VV0 stage_NN1 of_IO the_AT addiction_NN1 cycle_NN1 and_CC the_AT transition_NN1 to_II addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   39 Other measures of the withdrawal/negative affect stage include anxiety-like decreases in reward as measured by increases in threshold for brain stimulation reward and place aversions to a withdrawal stimulus .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   39 Other_JJ measures_NN2 of_IO the_AT withdrawal/negative_NN1 affect_NN1_VV0 stage_NN1 include_VV0 anxiety-like_JJ decreases_NN2@_VVZ in_II reward_NN1 as_CSA measured_VVN by_II increases_NN2 in_II threshold_NN1 for_IF brain_NN1 stimulation_NN1 reward_NN1 and_CC place_VV0_NN1 aversions_NN2 to_II a_AT1 withdrawal_NN1 stimulus_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   40 Increases in brain reward thresholds have been observed following withdrawal from psychomotor stimulants , opiates , ethanol , D9-tetrahydrocannabinol ( THC ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   40 Increases_NN2_VVZ in_II brain_NN1 reward_NN1 thresholds_NN2 have_VH0 been_VBN observed_VVN following_II@_VVG_JJ@ withdrawal_NN1 from_II psychomotor_NN1 stimulants_NN2 ,_Y opiates_NN2_VVZ ,_Y ethanol_NN1 ,_Y D9-tetrahydrocannabinol_NN1_JJ (_Y THC_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   41 <p> Human studies have shown that the presentation of drugs themselves , or stimuli previously associated with drug delivery or drug withdrawal , or the state Of stress , increase the likelihood of relapse as well as self-reports of craving and motivation to engage in drug-taking .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   41 <p>_Y Human_JJ_NN1 studies_NN2 have_VH0 shown_VVN that_CST the_AT presentation_NN1 of_IO drugs_NN2 themselves_PPX2 ,_Y or_CC stimuli_NN2 previously_RR associated_VVN with_IW drug_NN1 delivery_NN1 or_CC drug_NN1 withdrawal_NN1 ,_Y or_CC the_AT state_NN1 Of_IO stress_NN1 ,_Y increase_VV0 the_AT likelihood_NN1 of_IO relapse_NN1 as_II31 well_II32 as_II33 self-reports_NN2 of_IO craving_VVG_NN1@_JJ@ and_CC motivation_NN1 to_TO engage_VVI in_II drug-taking_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   42 Animal models have been developed that reflect all three stimuli important for relapse : ingestion of the drug itself , cues associated with the drug , of craving can be divided into two domains : drug-seeking induced by stimuli paired with drug-taking , and drug-seeking induced by an acute stressor or a state of stress .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   42 Animal_NN1 models_NN2 have_VH0 been_VBN developed_VVN that_CST reflect_VV0 all_DB three_MC stimuli_NN2 important_JJ for_IF relapse_NN1 :_Y ingestion_NN1 of_IO the_AT drug_NN1 itself_PPX1 ,_Y cues_NN2 associated_VVN with_IW the_AT drug_NN1 ,_Y of_IO craving_VVG_NN1@ can_VM be_VBI divided_VVN into_II two_MC domains_NN2 :_Y drug-seeking_NN1_JJ induced_VVN by_II stimuli_NN2 paired_VVN_VVD with_IW drug-taking_NN1 ,_Y and_CC drug-seeking_NN1_JJ induced_VVN by_II an_AT1 acute_JJ stressor_NN1 or_CC a_AT1 state_NN1 of_IO stress_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   43 Drug-seeking can be reinstated in animals that have acquired drug self-administration and then have been subjected to extinction of responding for the drug by the use of drug stimuli , cues paired with or predicting drug taking , and stress induction ( McFarland Kalivas , 2001 ; Shaham , Shalev , Lu , De Wit , Stewart , 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   43 Drug-seeking_NN1 can_VM be_VBI reinstated_VVN in_II animals_NN2 that_CST have_VH0 acquired_VVN drug_NN1 self-administration_NN1 and_CC then_RT have_VH0 been_VBN subjected_VVN to_II extinction_NN1 of_IO responding_VVG for_IF the_AT drug_NN1 by_II the_AT use_NN1 of_IO drug_NN1 stimuli_NN2 ,_Y cues_NN2 paired_VVN_VVD with_IW or_CC predicting_VVG drug_NN1 taking_VVG ,_Y and_CC stress_NN1_VV0@ induction_NN1 (_Y McFarland_NP1 Kalivas_NP2 ,_Y 2001_MC ;_Y Shaham_NP1 ,_Y Shalev_NP1 ,_Y Lu_NP1_NN1 ,_Y De_NP1 Wit_NN1 ,_Y Stewart_NP1 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   44 <p> L : NEUROCIRCUITRY OF DRUG REWARD AND ANTI-REWARD RELEVANT TO ADDICTION A key element of drug addiction is how the brain reward system changes with the development of addiction , and one must understand the neurobiological bases for acute drug reward to understand how these systems change as addiction develops .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   44 <p>_Y L_ZZ1_NP1@ :_Y NEUROCIRCUITRY_NN1_NP1 OF_IO DRUG_NN1 REWARD_NN1 AND_CC ANTI-REWARD_JJ RELEVANT_JJ TO_II ADDICTION_NPX A_ZZ1 key_JJ element_NN1 of_IO drug_NN1 addiction_NN1 is_VBZ how_RRQ the_AT brain_NN1 reward_NN1 system_NN1 changes_NN2_VVZ@ with_IW the_AT development_NN1 of_IO addiction_NN1 ,_Y and_CC one_PN1 must_VM understand_VVI the_AT neurobiological_JJ bases_NN2 for_IF acute_JJ drug_NN1 reward_NN1 to_TO understand_VVI how_RRQ these_DD2 systems_NN2 change_VV0 as_CSA_II@ addiction_NN1 develops_VVZ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   45 A principle focus of research on the neurobiology of the positive reinforcing effects of drugs of abuse has been the origins and terminal areas of the mesocorticolimbic dopamine system , and evidence for the importance of this system in psychostimulant reward is compelling ( Koob , to include other drugs , as well as the many neural inputs and outputs that interact with the dopamine projection from the ventral tegmental area to the basal forebrain and includes dopamine-independent components of drug reward ( Figure 2 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   45 A_AT1 principle_NN1 focus_NN1 of_IO research_NN1 on_II the_AT neurobiology_NN1 of_IO the_AT positive_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 has_VHZ been_VBN the_AT origins_NN2 and_CC terminal_JJ_NN1 areas_NN2 of_IO the_AT mesocorticolimbic_JJ dopamine_NN1 system_NN1 ,_Y and_CC evidence_NN1 for_IF the_AT importance_NN1 of_IO this_DD1 system_NN1 in_II psychostimulant_JJ_NN1 reward_NN1 is_VBZ compelling_JJ_VVG (_Y Koob_NP1 ,_Y to_TO include_VVI other_JJ drugs_NN2 ,_Y as_II31 well_II32 as_II33 the_AT many_DA2 neural_JJ inputs_NN2 and_CC outputs_VVZ_NN2 that_CST interact_VV0 with_IW the_AT dopamine_NN1 projection_NN1 from_II the_AT ventral_JJ tegmental_JJ area_NN1 to_II the_AT basal_JJ forebrain_NN1 and_CC includes_VVZ dopamine-independent_JJ components_NN2 of_IO drug_NN1 reward_NN1 (_Y Figure_NN1 2_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   46 <p> In addition to the mesocorticolimbic dopamine system and its projections , specific components of the basal forebrain have more recently been identified with the hedonic neuroadaptations to acute drug reward and have focused on elements of the extended amygdala ( Koob , 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   46 <p>_Y In_II31 addition_II32 to_II33 the_AT mesocorticolimbic_JJ dopamine_NN1 system_NN1 and_CC its_Z' projections_NN2 ,_Y specific_JJ components_NN2 of_IO the_AT basal_JJ forebrain_NN1 have_VH0 more_RGR recently_RR been_VBN identified_VVN with_IW the_AT hedonic_JJ neuroadaptations_NN2 to_II acute_JJ drug_NN1 reward_NN1 and_CC have_VH0 focused_VVN on_II elements_NN2 of_IO the_AT extended_JJ@ amygdala_NN1 (_Y Koob_NP1 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   47 As the neural circuits for the reinforcing effects of drugs of abuse have evolved , the role of neurotransmitters/ neuromodulators also have evolved , and four of those systems are discussed below ; mesolimbic dopamine , opioid peptide , gamma-aminobutyric acid ( GABA ) , and serotonin ( Table 1 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   47 As_II_CSA the_AT neural_JJ_NN1 circuits_NN2 for_IF the_AT reinforcing_JJ@ effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 have_VH0 evolved_VVN ,_Y the_AT role_NN1 of_IO neurotransmitters/_FU neuromodulators_NN2 also_RR have_VH0 evolved_VVN ,_Y and_CC four_MC of_IO those_DD2 systems_NN2 are_VBR discussed_VVN below_RL ;_Y mesolimbic_JJ dopamine_NN1 ,_Y opioid_JJ_NN1 peptide_NN1 ,_Y gamma-aminobutyric_JJ acid_NN1 (_Y GABA_NP1 )_Y ,_Y and_CC serotonin_NN1 (_Y Table_NN1 1_MC1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   48 Significant evidence exists for both dopamine-dependent and -independent neurocircuitry in drug reward with a focus on the nucleus accumbens and amygdala ( Koob , 1992 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   48 Significant_JJ evidence_NN1 exists_VVZ for_IF both_RR dopamine-dependent_JJ and_CC -independent_JJ neurocircuitry_NN1 in_II drug_NN1 reward_NN1 with_IW a_AT1 focus_NN1 on_II the_AT nucleus_NN1 accumbens_NN2 and_CC amygdala_NN1 (_Y Koob_NP1 ,_Y 1992_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   49 <p> All major drugs of abuse produce dysphoria during withdrawal , and animal models show an elevation of reward thresholds as measured by brain stimulation cocaine , opiates ' , alcohol , nicotine , and THC A logical explanation for the neuroadaptative mechanisms responsible for the negative motivational effects of drug withdrawal ( the " dark side ) may involve disruption of the same neural systems implicated in the positive reinforcing effects of drugs of abuse ( Table 1 ) ( Koob Le Moal , 2005 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   49 <p>_Y All_DB_RR@ major_JJ drugs_NN2 of_IO abuse_NN1 produce_VV0_NN1@ dysphoria_NN1 during_II withdrawal_NN1 ,_Y and_CC animal_NN1 models_NN2 show_VV0 an_AT1 elevation_NN1 of_IO reward_NN1 thresholds_NN2 as_CSA measured_VVN by_II brain_NN1 stimulation_NN1 cocaine_NN1 ,_Y opiates_NN2 '_GE ,_Y alcohol_NN1 ,_Y nicotine_NN1 ,_Y and_CC THC_NP1 A_ZZ1 logical_JJ explanation_NN1 for_IF the_AT neuroadaptative_JJ mechanisms_NN2 responsible_JJ for_IF the_AT negative_JJ motivational_JJ effects_NN2 of_IO drug_NN1 withdrawal_NN1 (_Y the_AT "_Y dark_JJ_NN1 side_NN1 )_Y may_VM involve_VVI disruption_NN1 of_IO the_AT same_DA neural_JJ_NN1 systems_NN2 implicated_VVD_VVN@ in_II the_AT positive_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 (_Y Table_NN1 1_MC1 )_Y (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   50 <p> As such , these effects may reflect changes in the activity of reward neurotransmitter systems in the midbrain and forebrain implicated in the positive reinforcing effects of drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   50 <p>_Y As_II such_DA ,_Y these_DD2 effects_NN2 may_VM reflect_VVI changes_NN2 in_II the_AT activity_NN1 of_IO reward_NN1 neurotransmitter_NN1_VV0 systems_NN2 in_II the_AT midbrain_NN1 and_CC forebrain_NN1 implicated_VVD_VVN@ in_II the_AT positive_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   51 Examples of such changes at the neurochemical level include decreases in dopaminergic and serotonergic transmission in the nucleus accumbens during drug withdrawal as measured by in vivo microdialysis , increased sensitivity of opioid receptor transduction mechanisms in the nucleus accumbens during opiate withdrawal , decreased GABAergic and increased N-methyl-D-aspartate ( NMDA ) glutamatergic transmission during alcohol withdrawal , and differential regional changes in nicotinic receptor function .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   51 Examples_NN2 of_IO such_DA changes_NN2 at_II the_AT neurochemical_JJ level_NN1 include_VV0 decreases_NN2@_VVZ in_II dopaminergic_JJ and_CC serotonergic_JJ transmission_NN1 in_II the_AT nucleus_NN1 accumbens_NN2 during_II drug_NN1 withdrawal_NN1 as_CSA measured_VVN by_II in_JJ21 vivo_JJ22 microdialysis_NN1 ,_Y increased_JJ_VVD sensitivity_NN1 of_IO opioid_JJ_NN1 receptor_NN1 transduction_NN1 mechanisms_NN2 in_II the_AT nucleus_NN1 accumbens_NN2 during_II opiate_NN1 withdrawal_NN1 ,_Y decreased_VVD_VVN GABAergic_JJ and_CC increased_VVD_JJ N-methyl-D-aspartate_NP1 (_Y NMDA_NP1 )_Y glutamatergic_JJ transmission_NN1 during_II alcohol_NN1 withdrawal_NN1 ,_Y and_CC differential_JJ regional_JJ changes_NN2 in_II nicotinic_JJ receptor_NN1 function_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   52 The decreases in reward neurotransmitters have been hypothesized to contribute significantly to the negative motivational state associated with acute drug abstinence and may trigger long-term biochemical changes that contribute to ( Koob Le Moal , 2001 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   52 The_AT decreases_NN2@ in_II reward_NN1 neurotransmitters_NN2 have_VH0 been_VBN hypothesized_VVN@ to_TO contribute_VVI significantly_RR to_II the_AT negative_JJ motivational_JJ state_NN1 associated_VVN with_IW acute_JJ drug_NN1 abstinence_NN1 and_CC may_VM trigger_VVI long-term_JJ biochemical_JJ changes_NN2 that_CST contribute_VV0 to_II (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2001_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   53 <p> However , different neurochemical systems involved in stress modulation also may be engaged within the neurocircuitry of the brain reward and stress systems in an attempt to overcome the chronic presence of the drug and to restore normal function despite its presence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   53 <p>_Y However_RR ,_Y different_JJ neurochemical_JJ systems_NN2 involved_JJ in_II stress_NN1 modulation_NN1 also_RR may_VM be_VBI engaged_VVN within_II the_AT neurocircuitry_NN1 of_IO the_AT brain_NN1 reward_NN1 and_CC stress_NN1_VV0@ systems_NN2 in_II an_AT1 attempt_NN1 to_TO overcome_VVI the_AT chronic_JJ presence_NN1 of_IO the_AT drug_NN1 and_CC to_TO restore_VVI normal_JJ function_NN1 despite_II its_Z' presence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   54 Chronic administration of drugs with dependence potential also dysregulate both the **30;5800;TOOLONG ( HPA ) axis and the brain stress system mediated by corticotropin-releasing factor ( CRF ) ( Heinrichs Koob , 2004 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   54 Chronic_JJ administration_NN1 of_IO drugs_NN2 with_IW dependence_NN1 potential_NN1 also_RR dysregulate_VV0 both_RR the_AT **30;5800;TOOLONG_JJ (_Y HPA_NP1 )_Y axis_NN1 and_CC the_AT brain_NN1 stress_NN1 system_NN1 mediated_VVD_VVN@ by_II corticotropin-releasing_JJ_NN1 factor_NN1 (_Y CRF_NP1 )_Y (_Y Heinrichs_NP2_VVZ@ Koob_NP1_VV0@ ,_Y 2004_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   55 CRF is a 41 amino acid polypeptide with a wide distribution throughout the brain but with high concentrations of cell bodies in the paraventricular nucleus of the hypothalamus , the basal forebrain , and notably the extended amygdala and brainstem .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   55 CRF_NP1 is_VBZ a_AT1 41_MC amino_NN1 acid_NN1 polypeptide_NN1 with_IW a_AT1 wide_JJ distribution_NN1 throughout_II the_AT brain_NN1 but_CCB with_IW high_JJ concentrations_NN2 of_IO cell_NN1 bodies_NN2 in_II the_AT paraventricular_JJ nucleus_NN1 of_IO the_AT hypothalamus_NN1 ,_Y the_AT basal_JJ forebrain_NN1 ,_Y and_CC notably_RR the_AT extended_JJ@ amygdala_NN1 and_CC brainstem_NN1_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   56 Central administration of CRF mimics the behavioral response to activation and stress in rodents .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   56 Central_JJ administration_NN1 of_IO CRF_NP1 mimics_VVZ the_AT behavioral_JJ_NN1 response_NN1 to_II activation_NN1 and_CC stress_NN1_VV0@ in_II rodents_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   57 Administration of competitive CRF receptor antagonists generally has the opposite effects .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   57 Administration_NN1 of_IO competitive_JJ CRF_NP1 receptor_NN1 antagonists_NN2 generally_RR has_VHZ the_AT opposite_JJ effects_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   58 Common responses include an activated HPA stress response , elevated adrenocorticotropic hormone and corticosteroids , and an activated brain stress response with activated amygdala CRF during acute withdrawal from all major drugs of abuse in drug-seeking observed in extended access and dependence ( Koob , 2008 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   58 Common_JJ responses_NN2 include_VV0 an_AT1 activated_JJ@ HPA_NN1 stress_NN1 response_NN1 ,_Y elevated_VVD_JJ_VVN adrenocorticotropic_JJ hormone_NN1 and_CC corticosteroids_NN2 ,_Y and_CC an_AT1 activated_JJ@ brain_NN1 stress_NN1 response_NN1 with_IW activated_JJ@ amygdala_NN1 CRF_NP1 during_II acute_JJ withdrawal_NN1 from_II all_DB major_JJ drugs_NN2 of_IO abuse_NN1 in_II drug-seeking_NN1 observed_VVN_VVD in_II extended_JJ@ access_NN1 and_CC dependence_NN1 (_Y Koob_NP1 ,_Y 2008_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   59 <p> Acute withdrawal from drugs of abuse also may increase the release of norepinephrine in the bed nucleus of the stria terminalis ( BNST ) and decrease levels of neuropeptide Y ( NPY ) in the central and medial nuclei of the amygdala ( Heilig , Koob , Ekman , Britton , 1994 ; Koob Le Moal , 2005 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   59 <p>_Y Acute_JJ withdrawal_NN1 from_II drugs_NN2 of_IO abuse_NN1 also_RR may_VM increase_VVI the_AT release_NN1 of_IO norepinephrine_NN1_JJ in_II the_AT bed_NN1 nucleus_NN1 of_IO the_AT stria_NN1 terminalis_NN1 (_Y BNST_NP1 )_Y and_CC decrease_VV0_NN1 levels_NN2 of_IO neuropeptide_NN1 Y_ZZ1 (_Y NPY_NP1 )_Y in_II the_AT central_JJ and_CC medial_JJ nuclei_NN2 of_IO the_AT amygdala_NN1 (_Y Heilig_NP1_VV0_NN1 ,_Y Koob_NP1 ,_Y Ekman_NP1_NN1 ,_Y Britton_NP1 ,_Y 1994_MC ;_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   60 <p> These results suggest not only a change in function of neurotransmitters associated with the acute reinforcing effects of drugs ( dopamine , opioid peptides , serotonin , and GABA ) during the development of dependence , but also recruitment of the brain arousal and stress systems ( glutamate , CRF , and norepinephrine ) and dysregulation of the NPY brain anti-stress system .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   60 <p>_Y These_DD2 results_NN2 suggest_VV0 not_XX only_RR a_AT1 change_NN1 in_II function_NN1 of_IO neurotransmitters_NN2 associated_VVN with_IW the_AT acute_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 (_Y dopamine_VV0_NN1 ,_Y opioid_JJ_NN1 peptides_NN2 ,_Y serotonin_NN1 ,_Y and_CC GABA_NP1_NN1 )_Y during_II the_AT development_NN1 of_IO dependence_NN1 ,_Y but_CCB also_RR recruitment_NN1 of_IO the_AT brain_NN1 arousal_NN1 and_CC stress_NN1_VV0@ systems_NN2 (_Y glutamate_NN1 ,_Y CRF_NP1 ,_Y and_CC norepinephrine_NN1_JJ )_Y and_CC dysregulation_NN1 of_IO the_AT NPY_JJ_NN1 brain_NN1 anti-stress_NN1_JJ system_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   61 These changes would represent a " between-system " neuroadaptation .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   61 These_DD2 changes_NN2 would_VM represent_VVI a_AT1 "_Y between-system_JJ_NN1 "_Y neuroadaptation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   62 Reward mechanisms in dependence are compromised by disruption of neurochemical systems involved in processing natural rewards and by recruitment of the anti-reward systems that represent neuroadaptation to the chronic exposure of the brain reward neurocircuitry to drugs of abuse ( neuroanatomical entity termed the extended amygdala thus may represent a common anatomical substrate for some aspects of acute drug reward and a common neuroanatomical substrate for the negative effects on reward function produced by stress that help drive compulsive drug administration .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   62 Reward_NN1_VV0@ mechanisms_NN2 in_II dependence_NN1 are_VBR compromised_VVN by_II disruption_NN1 of_IO neurochemical_JJ systems_NN2 involved_JJ in_II processing_VVG natural_JJ rewards_NN2 and_CC by_II recruitment_NN1 of_IO the_AT anti-reward_JJ_NN1 systems_NN2 that_CST represent_VV0 neuroadaptation_NN1 to_II the_AT chronic_JJ exposure_NN1 of_IO the_AT brain_NN1 reward_NN1 neurocircuitry_NN1 to_II drugs_NN2 of_IO abuse_NN1 (_Y neuroanatomical_JJ entity_NN1 termed_VVD_VVN the_AT extended_JJ@ amygdala_NN1 thus_RR may_VM represent_VVI a_AT1 common_JJ anatomical_JJ substrate_NN1 for_IF some_DD aspects_NN2 of_IO acute_JJ drug_NN1 reward_NN1 and_CC a_AT1 common_JJ neuroanatomical_JJ substrate_NN1 for_IF the_AT negative_JJ effects_NN2 on_II reward_NN1 function_NN1 produced_VVN by_II stress_NN1 that_CST_DD1 help_VV0_NN1 drive_VVI compulsive_JJ drug_NN1 administration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   63 The extended amygdala receives numerous afferents from limbic structures , such as the basolateral amygdala and hippocampus , and sends efferents to the medial part of the ventral pallidum and a large projection to the lateral hypothalamus , further defining the specific brain areas that interface classical limbic ( emotional ) structures with the extrapyramidal motor system ( Koob , 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   63 The_AT extended_JJ@ amygdala_NN1 receives_VVZ numerous_JJ afferents_NN2 from_II limbic_JJ structures_NN2 ,_Y such_II21 as_II22 the_AT basolateral_JJ_NN1 amygdala_NN1 and_CC hippocampus_NN1 ,_Y and_CC sends_VVZ efferents_NN2 to_II the_AT medial_JJ part_NN1 of_IO the_AT ventral_JJ pallidum_NN1 and_CC a_AT1 large_JJ projection_NN1 to_II the_AT lateral_JJ hypothalamus_NN1 ,_Y further_RRR defining_VVG the_AT specific_JJ brain_NN1 areas_NN2 that_CST interface_VV0 classical_JJ limbic_JJ (_Y emotional_JJ )_Y structures_NN2_VVZ@ with_IW the_AT extrapyramidal_JJ motor_NN1 system_NN1 (_Y Koob_NP1 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   64 <p> Animal models of " craving " involve the use of drug-primed reinstatement , cue-induced reinstatement , or stress-induced reinstatement in animals that acquire drug self-administration and then are subjected to extinction of responding for the drug .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   64 <p>_Y Animal_NN1 models_NN2 of_IO "_Y craving_VVG_NN1@ "_Y involve_VV0 the_AT use_NN1 of_IO drug-primed_JJ_NN1 reinstatement_NN1 ,_Y cue-induced_JJ_NN1 reinstatement_NN1 ,_Y or_CC stress-induced_JJ_NN1 reinstatement_NN1 in_II animals_NN2 that_CST acquire_VV0 drug_NN1 self-administration_NN1 and_CC then_RT are_VBR subjected_VVN to_II extinction_NN1 of_IO responding_VVG for_IF the_AT drug_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   65 Most evidence from animal studies suggests that drug-induced reinstatement is localized to a medial prefrontal cortex/nucleus accumbens/ventral pallidum circuit mediated by the neurotransmitter glutamate .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   65 Most_DAT evidence_NN1 from_II animal_NN1 studies_NN2 suggests_VVZ that_CST_DD1 drug-induced_JJ_NN1 reinstatement_NN1 is_VBZ localized_VVN@_JJ to_II a_AT1 medial_JJ prefrontal_JJ cortex/nucleus_NN1 accumbens/ventral_FU pallidum_NN1 circuit_NN1 mediated_VVD_VVN@ by_II the_AT neurotransmitter_NN1 glutamate_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   66 In contrast , neuropharmacological and neurobiological studies using animal models for cue-induced reinstatement involve the basolateral amygdala as a critical substrate with a drug , induced reinstatement .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   66 In_II contrast_NN1 ,_Y neuropharmacological_JJ and_CC neurobiological_JJ studies_NN2 using_VVG animal_NN1 models_NN2 for_IF cue-induced_JJ_NN1 reinstatement_NN1 involve_VV0 the_AT basolateral_JJ_NN1 amygdala_NN1 as_II_CSA a_AT1 critical_JJ substrate_NN1 with_IW a_AT1 drug_NN1 ,_Y induced_VVD_JJ@_VVN reinstatement_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   67 Stress-induced reinstatement of drug-related responding in animal models appears to depend on activation of both CRF and norepinephrine in elements of the extended amygdala ( central nucleus of the amygdala and BNST ) ( MCFarland Kalivas , 2001 ; Shaham et al. , 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   67 Stress-induced_JJ_NN1 reinstatement_NN1 of_IO drug-related_NN1_JJ responding_VVG in_II animal_NN1 models_NN2 appears_VVZ to_TO depend_VVI on_II activation_NN1 of_IO both_RR CRF_NP1 and_CC norepinephrine_NN1_JJ in_II elements_NN2 of_IO the_AT extended_JJ@ amygdala_NN1 (_Y central_JJ nucleus_NN1 of_IO the_AT amygdala_NN1 and_CC BNST_NP1 )_Y (_Y MCFarland_NP1 Kalivas_NP2 ,_Y 2001_MC ;_Y Shaham_NP1 et_RA21 al._RA22 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   68 In human imaging studies , another common element of drug dependence is decreased function in the orbitofrontal/medial prefrontal cortex as measured both by neuropsychological tests and imaging : ( Volkow Li , 2004 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   68 In_II human_JJ_NN1 imaging_NN1_VVG studies_NN2 ,_Y another_DD1 common_JJ element_NN1 of_IO drug_NN1 dependence_NN1 is_VBZ decreased_VVN_JJ@ function_NN1 in_II the_AT orbitofrontal/medial_JJ_NN1 prefrontal_JJ cortex_NN1 as_CSA measured_VVN both_RR by_II neuropsychological_JJ tests_NN2 and_CC imaging_NN1_VVG :_Y (_Y Volkow_NP1 Li_NP1 ,_Y 2004_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   69 <p> In summary , three neurobiological circuits have been identified as important to the study of the neurobiological changes associated with the development and persistence of drug dependence ( Koob Le Moal , 2006 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   69 <p>_Y In_II summary_NN1 ,_Y three_MC neurobiological_JJ circuits_NN2 have_VH0 been_VBN identified_VVN as_CSA_RG@_II@ important_JJ to_II the_AT study_NN1 of_IO the_AT neurobiological_JJ changes_NN2 associated_VVN with_IW the_AT development_NN1 and_CC persistence_NN1 of_IO drug_NN1 dependence_NN1 (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2006_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   70 The acute reinforcing effects of drugs of abuse that comprise the binge/intoxication stage of the addiction cycle most likely involve actions localized to a nucleus accumbens-amygdala reward system , dopamine inputs from the ventral tegmental area , local opioid peptide circuits , and opioid peptide inputs in the arcuate nucleus of the hypothalamus .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   70 The_AT acute_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 that_CST comprise_VV0 the_AT binge/intoxication_NN1 stage_NN1 of_IO the_AT addiction_NN1 cycle_NN1 most_RGT_DAT likely_RR@_JJ involve_VV0 actions_NN2 localized_VVD_VVN@ to_II a_AT1 nucleus_NN1 accumbens-amygdala_NN1_JJ reward_NN1 system_NN1 ,_Y dopamine_VV0_NN1 inputs_NN2 from_II the_AT ventral_JJ tegmental_JJ area_NN1 ,_Y local_JJ opioid_JJ_NN1 peptide_NN1 circuits_NN2 ,_Y and_CC opioid_JJ_NN1 peptide_NN1 inputs_NN2_VVZ@ in_II the_AT arcuate_JJ_NN1 nucleus_NN1 of_IO the_AT hypothalamus_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   71 In contrast , the symptoms of acute motivational withdrawal important for addiction withdrawal/negative affect stage , most likely involve decreases in function of the reward system and recruitment of brain stress neurocircuitry .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   71 In_II contrast_NN1 ,_Y the_AT symptoms_NN2 of_IO acute_JJ motivational_JJ withdrawal_NN1 important_JJ for_IF addiction_NN1 withdrawal/negative_NN1 affect_NN1_VV0 stage_NN1 ,_Y most_RGT_DAT likely_RR@_JJ involve_VV0 decreases_NN2@_VVZ in_II function_NN1 of_IO the_AT reward_NN1 system_NN1 and_CC recruitment_NN1 of_IO brain_NN1 stress_NN1 neurocircuitry_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   72 The **26;5832;TOOLONG ( or " craving " ) stage involves key afferent projections to the extended amygdala and nucleus accumbens , specifically the prefrontal cortex ( for drug-induced reinstatement ) and the basolateral amygdala ( for cue-induced reinstatement ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   72 The_AT **26;5832;TOOLONG_FO (_Y or_CC "_Y craving_VVG_NN1@_JJ@ "_Y )_Y stage_NN1 involves_VVZ key_JJ afferent_JJ_NN1 projections_NN2 to_II the_AT extended_JJ@ amygdala_NN1 and_CC nucleus_NN1 accumbens_NN2 ,_Y specifically_RR the_AT prefrontal_JJ cortex_NN1 (_Y for_IF drug-induced_JJ_NN1 reinstatement_NN1 )_Y and_CC the_AT basolateral_JJ_NN1 amygdala_NN1 (_Y for_IF cue-induced_JJ_NN1 reinstatement_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   73 Compulsive drug-seeking behavior is hypothesized to be driven by ventral striatal-ventral **26;5860;TOOLONG loops .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   73 Compulsive_JJ drug-seeking_JJ_NN1 behavior_NN1 is_VBZ hypothesized_VVN@_JJ@ to_TO be_VBI driven_VVN by_II ventral_JJ striatal-ventral_JJ **26;5860;TOOLONG_JJ loops_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   74 <p> L : MOLECULAR APPROACHES TO ADDICTION Many scientists feel that the modem age of drug abuse research began in the early 1970s with the discovery of the opioid receptors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   74 <p>_Y L_ZZ1_NP1@ :_Y MOLECULAR_JJ APPROACHES_NN2 TO_II ADDICTION_NPX Many_DA2 scientists_NN2 feel_VV0 that_CST the_AT modem_NN1 age_NN1 of_IO drug_NN1 abuse_NN1 research_NN1 began_VVD in_II the_AT early_JJ 1970s_MC2 with_IW the_AT discovery_NN1 of_IO the_AT opioid_JJ_NN1 receptors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   75 This discovery was made simultaneously by three laboratories , including that of Eric J. Simon , ( Pert Snyder 1973 ; Simon , Hiller , Edelman , 1973 ; Terenius , 1973 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   75 This_DD1 discovery_NN1 was_VBDZ made_VVN simultaneously_RR by_II three_MC laboratories_NN2 ,_Y including_II_VVG@ that_DD1 of_IO Eric_NP1 J._NP1 Simon_NP1 ,_Y (_Y Pert_JJ Snyder_NN1 1973_MC ;_Y Simon_NP1 ,_Y Hiller_NN1_NP1@ ,_Y Edelman_NP1_NN1 ,_Y 1973_MC ;_Y Terenius_NP1 ,_Y 1973_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   76 The discovery that opiate analgesics such as morphine or etorphine , as well as antagonists such as naloxone and diprenorphine , bind stereospecifically to animal and human brain homogenates , provided the initial evidence for the existence of these receptors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   76 The_AT discovery_NN1 that_CST_DD1 opiate_VV0_NN1 analgesics_NN2 such_II21 as_II22 morphine_NN1 or_CC etorphine_NN1_VV0 ,_Y as_II31 well_II32 as_II33 antagonists_NN2 such_II21 as_II22 naloxone_NN1 and_CC diprenorphine_NN1_VV0 ,_Y bind_VV0 stereospecifically_RR to_II animal_NN1 and_CC human_JJ_NN1 brain_NN1 homogenates_NN2_VVZ ,_Y provided_CS_VVD the_AT initial_JJ_NN1 evidence_NN1 for_IF the_AT existence_NN1 of_IO these_DD2 receptors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   77 This was quickly followed by evidence indicating that led to a rapid increase in molecular research on opiates and to several additional important discoveries in the opiate field .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   77 This_DD1 was_VBDZ quickly_RR followed_VVN by_II evidence_NN1 indicating_VVG that_CST led_VVN_VVD to_II a_AT1 rapid_JJ increase_NN1 in_II molecular_JJ research_NN1 on_II opiates_NN2 and_CC to_II several_DA2 additional_JJ important_JJ discoveries_NN2 in_II the_AT opiate_NN1 field_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   78 One was the finding that there are three types of opioid receptors , mu ( MOP ) , delta ( DOP ) , and kappa ( KOP ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   78 One_PN1_MC1 was_VBDZ the_AT finding_NN1 that_CST there_EX are_VBR three_MC types_NN2 of_IO opioid_JJ_NN1 receptors_NN2 ,_Y mu_NN1 (_Y MOP_NN1_VV0 )_Y ,_Y delta_NN1 (_Y DOP_NP1 )_Y ,_Y and_CC kappa_NN1 (_Y KOP_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   79 All three have distinct distributions in the brain , properties , and actions .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   79 All_DB three_MC have_VH0 distinct_JJ distributions_NN2 in_II the_AT brain_NN1 ,_Y properties_NN2 ,_Y and_CC actions_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   80 The Simon laboratory pioneered the purification of these receptors , making pure proteins available to investigators for structural and functional studies ( Gioannini , Howard , Hiller , Simon , 1985 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   80 The_AT Simon_NP1 laboratory_NN1 pioneered_VVD_VVN the_AT purification_NN1 of_IO these_DD2 receptors_NN2 ,_Y making_VVG pure_JJ proteins_NN2 available_JJ to_II investigators_NN2 for_IF structural_JJ and_CC functional_JJ studies_NN2 (_Y Gioannini_NP1_NN1 ,_Y Howard_NP1 ,_Y Hiller_NN1_NP1@ ,_Y Simon_NP1 ,_Y 1985_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   81 Such pure receptors were reconstituted with pure G-proteins and phospholipids to form an active complex , able to bind both opioid agonists and antagonists with high affinity in vitro ( Gioannini et al. , 1993 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   81 Such_DA pure_JJ receptors_NN2 were_VBDR reconstituted_VVN with_IW pure_JJ G-proteins_NN2 and_CC phospholipids_NN2 to_TO form_VVI an_AT1 active_JJ complex_NN1_JJ ,_Y able_JK to_TO bind_VVI both_RR_DB2 opioid_JJ agonists_NN2 and_CC antagonists_NN2 with_IW high_JJ affinity_NN1 in_RR21_JJ21 vitro_RR22_JJ22 (_Y Gioannini_NP1 et_RA21 al._RA22 ,_Y 1993_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   82 <p> Scientists posed the obvious question : Why are there receptors in the brain that bind morphine and synthetic drugs ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   82 <p>_Y Scientists_NN2 posed_VVD_VVN the_AT obvious_JJ question_NN1 :_Y Why_RRQ are_VBR there_RL_EX receptors_NN2 in_II the_AT brain_NN1 that_CST bind_VV0 morphine_NN1 and_CC synthetic_JJ drugs_NN2 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   83 Why have these receptors survived eons of evolution ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   83 Why_RRQ have_VH0 these_DD2 receptors_NN2 survived_VVN eons_NN2 of_IO evolution_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   84 What is their real physiological function ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   84 What_DDQ is_VBZ their_APPGE real_JJ physiological_JJ function_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   85 This led to the next important <p> What is the value of knowing the DNA structures ( nucleotide sequences ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   85 This_DD1 led_VVD_VVN to_II the_AT next_MD important_JJ <p>_Y What_DDQ is_VBZ the_AT value_NN1 of_IO knowing_VVG the_AT DNA_NN1 structures_NN2 (_Y nucleotide_VV0_NN1 sequences_NN2 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   86 DNA cloning has led to significant advances in techniques that have had a huge impact on biomedical research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   86 DNA_NN1 cloning_NN1 has_VHZ led_VVN to_II significant_JJ advances_NN2 in_II techniques_NN2 that_CST have_VH0 had_VHN a_AT1 huge_JJ impact_NN1 on_II biomedical_JJ research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   87 Some of these techniques are explained here , with a focus on their applications to the study of opioids ( Table 4 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   87 Some_DD of_IO these_DD2 techniques_NN2 are_VBR explained_VVN here_RL ,_Y with_IW a_AT1 focus_NN1 on_II their_APPGE applications_NN2 to_II the_AT study_NN1 of_IO opioids_NN2 (_Y Table_NN1 4_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   88 <p> breakthrough , the discovery of substances in the brain and other tissues with morphine-like activity , often called endorphins ( a term coined by Simon ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   88 <p>_Y breakthrough_NN1 ,_Y the_AT discovery_NN1 of_IO substances_NN2 in_II the_AT brain_NN1 and_CC other_JJ tissues_NN2 with_IW morphine-like_JJ activity_NN1 ,_Y often_RR called_VVN endorphins_NN2 (_Y a_AT1 term_NN1 coined_VVD_VVN@ by_II Simon_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   89 These substances were determined to be peptides ( short chains of amino acids , ranging in size from 5 amino acids for enkephalins to 32 amino acids for beta-endorphin ) , Table 3 lists the known opioid peptides and their amino acid sequences , expressed in the single-letter nomenclature of amino acids , such as Y for Tyrosine , G for glycine , etc. ( the complete list of amino acid single-letter sequences is readily available in any biochemistry textbook for those who are interested ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   89 These_DD2 substances_NN2 were_VBDR determined_VVN to_TO be_VBI peptides_NN2 (_Y short_JJ chains_NN2 of_IO amino_NN1 acids_NN2 ,_Y ranging_VVG in_II size_NN1 from_II 5_MC amino_NN1 acids_NN2 for_IF enkephalins_NN2 to_II 32_MC amino_NN1 acids_NN2 for_IF beta-endorphin_NN1_JJ )_Y ,_Y Table_NN1 3_MC lists_VVZ_NN2 the_AT known_JJ@ opioid_JJ_NN1 peptides_NN2 and_CC their_APPGE amino_NN1 acid_NN1 sequences_NN2 ,_Y expressed_VVN_VVD in_II the_AT single-letter_JJ_NN1 nomenclature_NN1 of_IO amino_NN1 acids_NN2 ,_Y such_II21 as_II22 Y_ZZ1_NP1@ for_IF Tyrosine_NP1 ,_Y G_ZZ1 for_IF glycine_NN1 ,_Y etc._RA (_Y the_AT complete_JJ list_NN1 of_IO amino_NN1 acid_NN1 single-letter_NN1_JJ sequences_NN2 is_VBZ readily_RR available_JJ in_II any_DD biochemistry_NN1 textbook_NN1 for_IF those_DD2 who_PNQS are_VBR interested_JJ )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   90 J <p> A series of exciting and outstanding studies led to an understanding of how these opioid peptides are biosynthesized ( see Simon Hiller , 1994 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   90 J_ZZ1_NP1@ <p>_Y A_AT1_ZZ1 series_NN of_IO exciting_JJ and_CC outstanding_JJ studies_NN2 led_VVN_VVD to_II an_AT1 understanding_NN1 of_IO how_RRQ these_DD2 opioid_JJ peptides_NN2 are_VBR biosynthesized_VVN@_JJ@ (_Y see_VV0 Simon_NP1 Hiller_NP1@_NN1 ,_Y 1994_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   91 All of them , proenkephalin , and prodynorphin .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   91 All_DB of_IO them_PPHO2 ,_Y proenkephalin_NN1 ,_Y and_CC prodynorphin_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   92 Opiomelanocortin is of particular interest because it is the precursor for several important and seemingly unrelated biologically active molecules , namely , b-endorphin , adrenocorticotropic hormone , and several melanocyte-stimulating hormones .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   92 Opiomelanocortin_NN1_NP1@ is_VBZ of_IO particular_JJ interest_NN1 because_CS it_PPH1 is_VBZ the_AT precursor_NN1 for_IF several_DA2 important_JJ and_CC seemingly_RR unrelated_JJ biologically_RR active_JJ molecules_NN2 ,_Y namely_REX ,_Y b-endorphin_NN1_JJ ,_Y adrenocorticotropic_JJ hormone_NN1 ,_Y and_CC several_DA2 melanocyte-stimulating_JJ hormones_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   93 <p> Once these precursors and their structures were known , there was a race to Clone them .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   93 <p>_Y Once_RR_CS@ these_DD2 precursors_NN2 and_CC their_APPGE structures_NN2 were_VBDR known_VVN ,_Y there_EX was_VBDZ a_AT1 race_NN1 to_TO_II Clone_VV0 them_PPHO2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   94 The term cloning is an unfortunate term It refers here to the purification I .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   94 The_AT term_NN1 cloning_NN1 is_VBZ an_AT1 unfortunate_JJ term_NN1 It_PPH1 refers_VVZ here_RL to_II the_AT purification_NN1 I_ZZ1%_MC1%_PPIS1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   95 !
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   95 !_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   96 and nucleotide sequencing of the DNA of a gene .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   96 and_CC nucleotide_VV0_NN1 sequencing_NN1 of_IO the_AT DNA_NN1 of_IO a_AT1 gene_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   97 The structure of the protein can then be inferred by using the universal genetic code to translate nucleotide triplets ( codons ) into amino acids The structure of the full gene with its long introns can also be readily attained .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   97 The_AT structure_NN1 of_IO the_AT protein_NN1 can_VM then_RT be_VBI inferred_VVN by_II using_VVG the_AT universal_JJ genetic_JJ code_NN1 to_TO translate_VVI nucleotide_NN1 triplets_NN2 (_Y codons_NN2 )_Y into_II amino_NN1 acids_NN2 The_AT structure_NN1 of_IO the_AT full_JJ gene_NN1 with_IW its_Z' long_JJ introns_NN2 can_VM also_RR be_VBI readily_RR attained_VVN_VVD ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   98 The DNA sequences were successfully determined for the genes encoding the three opioid peptide precursors , the first of which was the opiomelanocortin gene ( Noda et al. , 1982 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   98 The_AT DNA_NN1 sequences_NN2 were_VBDR successfully_RR determined_VVN for_IF the_AT genes_NN2 encoding_VVG the_AT three_MC opioid_JJ peptide_NN1 precursors_NN2 ,_Y the_AT first_MD of_IO which_DDQ was_VBDZ the_AT opiomelanocortin_NN1 gene_NN1 (_Y Noda_NP1 et_RA21 al._RA22 ,_Y 1982_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0   99 <p> More recently , the gene and protein sequences for the three types of opioid receptors also have been identified .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0   99 <p>_Y More_RGR_RRR recently_RR ,_Y the_AT gene_NN1 and_CC protein_NN1 sequences_NN2 for_IF the_AT three_MC types_NN2 of_IO opioid_JJ_NN1 receptors_NN2 also_RR have_VH0 been_VBN identified_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  100 The first to be cloned was the delta receptor ( Evans , Keith , Morrison Befort , Ruff , Hirth , 1992 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  100 The_AT first_MD to_TO be_VBI cloned_VVN@ was_VBDZ the_AT delta_NN1 receptor_NN1 (_Y Evans_NP1 ,_Y Keith_NP1 ,_Y Morrison_NP1 Befort_NP1_VV0_NN1 ,_Y Ruff_NN1 ,_Y Hirth_NP1_NN1 ,_Y 1992_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  101 All three types have since been cloned , and no genes for additional opioid receptor types have subsequently been discovered .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  101 All_DB three_MC types_NN2 have_VH0 since_RR@ been_VBN cloned_VVN@ ,_Y and_CC no_AT genes_NN2 for_IF additional_JJ opioid_JJ_NN1 receptor_NN1 types_NN2 have_VH0 subsequently_RR been_VBN discovered_VVN@ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  102 The knowledge of the sequence of the " reading frame " of the genes and the resulting knowledge of the amino acid sequence of the receptor proteins confirmed previous pharmacological studies that had suggested opioid receptors are members of the large family of G protein-coupled receptors and have the typical structure of such receptors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  102 The_AT knowledge_NN1 of_IO the_AT sequence_NN1 of_IO the_AT "_Y reading_NN1 frame_NN1 "_Y of_IO the_AT genes_NN2 and_CC the_AT resulting_JJ knowledge_NN1 of_IO the_AT amino_NN1 acid_NN1 sequence_NN1 of_IO the_AT receptor_NN1 proteins_NN2 confirmed_VVD_VVN previous_JJ pharmacological_JJ studies_NN2 that_CST had_VHD suggested_VVN opioid_JJ_NN1 receptors_NN2 are_VBR members_NN2 of_IO the_AT large_JJ family_NN1 of_IO G_ZZ1 protein-coupled_JJ receptors_NN2 and_CC have_VH0 the_AT typical_JJ structure_NN1 of_IO such_DA receptors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  103 <p> L : SITE-DIRECTED MUTATIONS AND DELETIONS The DNA of a gene can be manipulated by creating mutations , replacing or deleting nucleotides that change the code for an amino acid , and eliminating a portion of the gene .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  103 <p>_Y L_ZZ1_NP1@ :_Y SITE-DIRECTED_JJ MUTATIONS_NN2 AND_CC DELETIONS_NP1_NN2 The_AT DNA_NN1 of_IO a_AT1 gene_NN1 can_VM be_VBI manipulated_VVN by_II creating_VVG mutations_NN2 ,_Y replacing_VVG or_CC deleting_VVG nucleotides_NN2 that_CST change_VV0 the_AT code_NN1 for_IF an_AT1 amino_NN1 acid_NN1 ,_Y and_CC eliminating_VVG a_AT1 portion_NN1 of_IO the_AT gene_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  104 Thus , the codon for a single amino acid in a crucial area of the molecule can be altered or a portion of the DNA deleted , such as the DNA coding for the carboxyl tail of an opioid receptor .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  104 Thus_RR ,_Y the_AT codon_NN1 for_IF a_AT1 single_JJ amino_NN1 acid_NN1 in_II a_AT1 crucial_JJ area_NN1 of_IO the_AT molecule_NN1 can_VM be_VBI altered_VVN_JJ or_CC a_AT1 portion_NN1 of_IO the_AT DNA_NN1 deleted_VVD_VVN ,_Y such_II21 as_II22 the_AT DNA_NN1 coding_VVG_NN1 for_IF the_AT carboxyl_NN1 tail_NN1 of_IO an_AT1 opioid_JJ_NN1 receptor_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  105 Such altered genes then can be introduced into cells in culture or into animals , and the effects of these changes on the phenotype One can now take part of the DNA encoding one molecule ( e.g. , the mu opioid receptor ) and another portion of the DNA encoding another molecule ( e.g. , the delta opioid receptor ) and create a chimera .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  105 Such_DA altered_JJ genes_NN2 then_RT can_VM be_VBI introduced_VVN into_II cells_NN2 in_II culture_NN1 or_CC into_II animals_NN2 ,_Y and_CC the_AT effects_NN2 of_IO these_DD2 changes_NN2 on_II the_AT phenotype_NN1 One_PN1_MC1 can_VM now_RT take_VVI part_NN1 of_IO the_AT DNA_NN1 encoding_VVG one_MC1 molecule_NN1 (_Y e.g._REX ,_Y the_AT mu_NN1 opioid_NN1_JJ receptor_NN1 )_Y and_CC another_DD1 portion_NN1 of_IO the_AT DNA_NN1 encoding_VVG another_DD1 molecule_NN1 (_Y e.g._REX ,_Y the_AT delta_NN1 opioid_NN1_JJ receptor_NN1 )_Y and_CC create_VV0 a_AT1 chimera_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  106 One can then ask questions about which properties and functions come from one or the other receptor .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  106 One_PN1 can_VM then_RT ask_VVI questions_NN2 about_II which_DDQ properties_NN2 and_CC functions_NN2 come_VV0_VVN@ from_II one_MC1 or_CC the_AT other_JJ receptor_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  107 <p> L : KNOCKOUT AND TRANSGENIC ANIMALS It is possible to generate knockout or transgenic animals .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  107 <p>_Y L_ZZ1_NP1@ :_Y KNOCKOUT_NP1_VV0_NN1 AND_CC TRANSGENIC_JJ_NP1 ANIMALS_NN2 It_PPH1 is_VBZ possible_JJ to_TO generate_VVI knockout_NN1 or_CC transgenic_JJ animals_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  108 Mice are most commonly used for this purpose .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  108 Mice_NN2 are_VBR most_RGT commonly_RR used_VVN_VVD for_IF this_DD1 purpose_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  109 Knockout mice are those that have only an inactive form of the gene under study and therefore lack an active protein ( e.g. , one or more of the opioid receptors or peptides ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  109 Knockout_VV0_NN1 mice_NN2 are_VBR those_DD2 that_CST have_VH0 only_RR an_AT1 inactive_JJ form_NN1 of_IO the_AT gene_NN1 under_II study_NN1 and_CC therefore_RR lack_VV0@ an_AT1 active_JJ protein_NN1 (_Y e.g._REX ,_Y one_MC1 or_CC more_DAR of_IO the_AT opioid_JJ_NN1 receptors_NN2 or_CC peptides_NN2 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  110 A transgenic mouse has a gene that has been transferred and is not normally expressed ( e.g. , a gene for the human opioid receptor or a molecule it does not normally make or a gene that has been manipulated by mutation or deletion ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  110 A_AT1_ZZ1 transgenic_JJ mouse_NN1 has_VHZ a_AT1 gene_NN1 that_CST_DD1 has_VHZ been_VBN transferred_VVN and_CC is_VBZ not_XX normally_RR expressed_VVN (_Y e.g._REX ,_Y a_AT1 gene_NN1 for_IF the_AT human_JJ_NN1 opioid_JJ_NN1 receptor_NN1 or_CC a_AT1 molecule_NN1 it_PPH1 does_VDZ not_XX normally_RR make_VVI or_CC a_AT1 gene_NN1 that_CST_DD1 has_VHZ been_VBN manipulated_VVN by_II mutation_NN1 or_CC deletion_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  111 The phenotype of such mice can now be probed by behavioral , electrophysiological , pharmacological , and metabolic measurements to determine the impact of the Kieffer Gaveriaux-Ruff , 2002 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  111 The_AT phenotype_NN1 of_IO such_DA mice_NN2 can_VM now_RT be_VBI probed_VVN by_II behavioral_NN1_JJ ,_Y electrophysiological_JJ ,_Y pharmacological_JJ ,_Y and_CC metabolic_JJ measurements_NN2 to_TO determine_VVI the_AT impact_NN1 of_IO the_AT Kieffer_NP1 Gaveriaux-Ruff_NP1 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  112 <p> L : MICROARRAYS TO STUDY GENE EXPRESSION Microarrays , arrays of thousands of genes of interest on a tiny chip , have recently become available .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  112 <p>_Y L_ZZ1_NP1@ :_Y MICROARRAYS_NP2_VVZ_NN2 TO_TO STUDY_VVI GENE_NN1 EXPRESSION_NN1 Microarrays_NN2_VVZ_NP1 ,_Y arrays_NN2 of_IO thousands_M of_IO genes_NN2 of_IO interest_NN1 on_II a_AT1 tiny_JJ chip_NN1 ,_Y have_VH0 recently_RR become_VV0 available_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  113 Only those genes that anneal with messenger RNA ( the gene product that is the intermediate for protein synthesis ) from the tissue under study are expressed in that tissue and under the given physiological or pathological conditions .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  113 Only_RR those_DD2 genes_NN2 that_CST_DD1 anneal_JJ with_IW messenger_NN1 RNA_NN1 (_Y the_AT gene_NN1 product_NN1 that_CST_DD1 is_VBZ the_AT intermediate_JJ for_IF protein_NN1 synthesis_NN1 )_Y from_II the_AT tissue_NN1 under_II study_NN1 are_VBR expressed_VVN in_II that_DD1 tissue_NN1 and_CC under_II the_AT given_JJ@ physiological_JJ or_CC pathological_JJ conditions_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  114 This allows changes in the level of gene expression in various physiological of pathological conditions to be determined .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  114 This_DD1 allows_VVZ changes_NN2 in_II the_AT level_NN1 of_IO gene_NN1 expression_NN1 in_II various_JJ physiological_JJ of_IO pathological_JJ conditions_NN2 to_TO be_VBI determined_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  115 For example , one can ask what brain genes are turned up , turned down , or turned on or off , when a dependent rat is withdrawn from a drug or when an animal is given cues that lead to craving for a drug .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  115 For_REX21 example_REX22 ,_Y one_PN1 can_VM ask_VVI what_DDQ brain_NN1_VV0% genes_NN2 are_VBR turned_VVN up_RP ,_Y turned_VVD_VVN down_RP ,_Y or_CC turned_VVD_VVN on_RP@_II or_CC off_RP ,_Y when_CS_RRQ a_AT1 dependent_JJ rat_NN1 is_VBZ withdrawn_VVN from_II a_AT1 drug_NN1 or_CC when_CS_RRQ an_AT1 animal_NN1 is_VBZ given_VVN_JJ@ cues_NN2 that_CST lead_VV0_NN1 to_II craving_VVG for_IF a_AT1 drug_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  116 <p> L : STUDY OF SINGLE NUCLEOTIDE POLYMORPHISMS AND OTHER GENETIC VARIANTS Many mutations ( alleles ) exist in human and animal cells and often do not drastically change the phenotype but rather could produce subtle changes .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  116 <p>_Y L_ZZ1_NP1@ :_Y STUDY_NN1 OF_IO SINGLE_JJ NUCLEOTIDE_NN1 POLYMORPHISMS_NN2 AND_CC OTHER_JJ GENETIC_JJ VARIANTS_NN2 Many_DA2 mutations_NN2 (_Y alleles_NN2 )_Y exist_VV0 in_II_RP@ human_NN1_JJ and_CC animal_NN1 cells_NN2 and_CC often_RR do_VD0 not_XX drastically_RR change_VVI the_AT phenotype_NN1 but_CCB rather_RR@ could_VM produce_VVI subtle_JJ changes_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  117 The reason for the relatively mild effects of such mutants is either because the altered essential for the function of the protein or because the change in the nucleotide does not result in a change in the amino acid .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  117 The_AT reason_NN1 for_IF the_AT relatively_RR mild_JJ effects_NN2 of_IO such_DA mutants_NN2 is_VBZ either_RR because_CS the_AT altered_JJ essential_JJ for_IF the_AT function_NN1 of_IO the_AT protein_NN1 or_CC because_CS the_AT change_NN1 in_II the_AT nucleotide_NN1 does_VDZ not_XX result_VVI in_II a_AT1 change_NN1 in_II the_AT amino_NN1 acid_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  118 Such natural mutations are called single nucleotide polymorphisms ( SNPs ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  118 Such_DA natural_JJ mutations_NN2 are_VBR called_VVN single_JJ nucleotide_NN1 polymorphisms_NN2 (_Y SNPs_NP2 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  119 Many laboratories are now attempting to determine whether such SNPs have subtle effects on phenotype and thus may contribute , for example , to the striking differences observed between individuals in their sensitivity to the addicting effects of abused drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  119 Many_DA2 laboratories_NN2 are_VBR now_RT attempting_VVG to_TO determine_VVI whether_CSW such_DA SNPs_NP2 have_VH0 subtle_JJ effects_NN2 on_II phenotype_NN1 and_CC thus_RR may_VM contribute_VVI ,_Y for_REX21 example_REX22 ,_Y to_II the_AT striking_JJ differences_NN2 observed_VVN_VVD between_II individuals_NN2 in_II their_APPGE sensitivity_NN1 to_II the_AT addicting_JJ@_NN1@ effects_NN2 of_IO abused_JJ@ drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  120 <p> L : SPECIES DIFFERENCES AND EVOLUTIONARY CHANGES IN GENE STRUCTURE The complete sequencing of the human genome and that of many other creatures , animals , microorganisms , and plants , has made possible the study of changes in gene structure as never before These advances have already improved understanding of species differences and of the workings of evolution .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  120 <p>_Y L_ZZ1_NP1@ :_Y SPECIES_NN DIFFERENCES_NN2 AND_CC EVOLUTIONARY_JJ CHANGES_NN2 IN_II GENE_NN1_NP1@ STRUCTURE_NN1 The_AT complete_JJ sequencing_NN1 of_IO the_AT human_JJ_NN1 genome_NN1 and_CC that_DD1 of_IO many_DA2 other_JJ creatures_NN2 ,_Y animals_NN2 ,_Y microorganisms_NN2 ,_Y and_CC plants_NN2 ,_Y has_VHZ made_VVN possible_JJ the_AT study_NN1 of_IO changes_NN2 in_II gene_NN1 structure_NN1 as_CSA_RG@ never_RR before_RT These_DD2 advances_NN2 have_VH0 already_RR improved_VVN understanding_NN1 of_IO species_NN differences_NN2 and_CC of_IO the_AT workings_NN2 of_IO evolution_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  121 Such genomic approaches will likely further our understanding , prevention , and treatment of human diseases .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  121 Such_DA genomic_JJ approaches_NN2 will_VM likely_RR@ further_RRR our_APPGE understanding_NN1 ,_Y prevention_NN1 ,_Y and_CC treatment_NN1 of_IO human_JJ_NN1 diseases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  122 including drug addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  122 including_II drug_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  123 <p> L : STUDIES OF GENE EXPRESSION AND PROMOTER REGULATION BY TRANSCRIPTION FACTORS Finally , studies in which levels of gene expression and promoter regulation by proteins called transcription factors are promoter region , where gene activity is turned on or off , and where , when on , the level of gene transcription is regulated .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  123 <p>_Y L_ZZ1_NP1@ :_Y STUDIES_NN2 OF_IO GENE_NN1_NP1@ EXPRESSION_NN1 AND_CC PROMOTER_NN1 REGULATION_NN1 BY_II TRANSCRIPTION_NN1 FACTORS_NN2 Finally_RR ,_Y studies_NN2 in_II which_DDQ levels_NN2 of_IO gene_NN1 expression_NN1 and_CC promoter_NN1 regulation_NN1 by_II proteins_NN2 called_VVN_VVD@ transcription_NN1 factors_NN2 are_VBR promoter_NN1 region_NN1 ,_Y where_CS_RRQ gene_NN1 activity_NN1 is_VBZ turned_VVN on_RP@_II or_CC off_RP ,_Y and_CC where_RRQ_CS ,_Y when_CS_RRQ on_II_RP@ ,_Y the_AT level_NN1 of_IO gene_NN1 transcription_NN1 is_VBZ regulated_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  124 Understanding how gene expression is regulated is of considerable importance .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  124 Understanding_VVG_NN1 how_RRQ gene_NN1 expression_NN1 is_VBZ regulated_VVN is_VBZ of_IO considerable_JJ importance_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  125 These sophisticated experiments are best performed in cell culture , although studies in animals are becoming more and more possible Numerous transcription factors have already been discovered , resulting in a better understanding of how gene transcription and replication are controlled .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  125 These_DD2 sophisticated_JJ experiments_NN2 are_VBR best_RRT performed_VVN in_II cell_NN1 culture_NN1 ,_Y although_CS studies_NN2 in_II animals_NN2 are_VBR becoming_VVG more_RRR_DAR_RGR and_CC more_RGR possible_JJ Numerous_JJ transcription_NN1 factors_NN2 have_VH0 already_RR been_VBN discovered_VVN@ ,_Y resulting_VVG in_II a_AT1 better_JJR understanding_NN1 of_IO how_RRQ gene_NN1 transcription_NN1 and_CC replication_NN1 are_VBR controlled_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  126 The cloning of genes has led to numerous experimental approaches that were heretofore impossible , and many of these are powerful techniques that are already providing information we never dreamed of being able to obtain .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  126 The_AT cloning_NN1 of_IO genes_NN2 has_VHZ led_VVN to_II numerous_JJ experimental_JJ approaches_NN2 that_CST were_VBDR heretofore_RR impossible_JJ ,_Y and_CC many_DA2 of_IO these_DD2 are_VBR powerful_JJ techniques_NN2 that_CST are_VBR already_RR providing_VVG information_NN1 we_PPIS2 never_RR dreamed_VVN_VVD of_IO being_VBG able_JK to_TO obtain_VVI ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  127 <p> L : SIGNAL TRANSDUCTION The final topic to be discussed is the exciting research area known as signal transduction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  127 <p>_Y L_ZZ1_NP1@ :_Y SIGNAL_NN1_VV0@ TRANSDUCTION_NN1_NP1 The_AT final_JJ_NN1 topic_NN1 to_TO be_VBI discussed_VVN is_VBZ the_AT exciting_JJ research_NN1 area_NN1 known_VVN as_II signal_NN1 transduction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  128 These investigations probe the chemical reactions that allow the signal generated by a ligand ( e.g. , opiate drug or opioid peptide ) binding to a receptor to be transduced to the site at which the action of the ligand or drug takes place .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  128 These_DD2 investigations_NN2 probe_VV0 the_AT chemical_JJ_NN1 reactions_NN2 that_CST allow_VV0 the_AT signal_NN1 generated_VVN by_II a_AT1 ligand_NN1 (_Y e.g._REX ,_Y opiate_VV0_NN1 drug_NN1 or_CC opioid_JJ_NN1 peptide_NN1 )_Y binding_VVG to_II a_AT1 receptor_NN1 to_TO be_VBI transduced_VVN@ to_II the_AT site_NN1 at_II which_DDQ the_AT action_NN1 of_IO the_AT ligand_NN1 or_CC drug_NN1 takes_VVZ place_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  129 Numerous laboratories have made much progress in our understanding of in this area is the study of opioid receptors ( and other G protein-coupled receptors ) where there is activation of protein-phosphorylating enzymes , called mitogen-activated protein ( MAP ) kinases .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  129 Numerous_JJ laboratories_NN2 have_VH0 made_VVN much_DA1 progress_NN1 in_II our_APPGE understanding_NN1 of_IO in_II this_DD1 area_NN1 is_VBZ the_AT study_NN1 of_IO opioid_JJ_NN1 receptors_NN2 (_Y and_CC other_JJ G_ZZ1 protein-coupled_JJ receptors_NN2 )_Y where_RRQ_CS there_EX is_VBZ activation_NN1 of_IO protein-phosphorylating_JJ_NN1 enzymes_NN2 ,_Y called_VVN_VVD@ mitogen-activated_JJ_NN1 protein_NN1 (_Y MAP_NN1 )_Y kinases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  130 This ability had previously been thought to be restricted to hormone and growth factor receptors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  130 This_DD1 ability_NN1 had_VHD previously_RR been_VBN thought_VVN to_TO be_VBI restricted_VVN to_II hormone_NN1 and_CC growth_NN1 factor_NN1 receptors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  131 These MAP kinases are known to be involved in changes in gene expression , via phosphorylation of transcription factors , clearly important for the type of adaptations seen in drug dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  131 These_DD2 MAP_NN1_VV0@ kinases_NN2 are_VBR known_VVN to_TO be_VBI involved_JJ in_II changes_NN2 in_II gene_NN1 expression_NN1 ,_Y via_II phosphorylation_NN1 of_IO transcription_NN1 factors_NN2 ,_Y clearly_RR important_JJ for_IF the_AT type_NN1 of_IO adaptations_NN2 seen_VVN in_II drug_NN1 dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  132 The Simon laboratory and that of Susan George were able to show independently that MAP kinase activation involves phosphorylation of tyrosine residues on the delta and mu opioid receptors , respectively ( Kramer , Andria , Esposito , Simon , 2000 ; Pak , O'Dowd , Wang , George , 1999 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  132 The_AT Simon_NP1 laboratory_NN1 and_CC that_DD1 of_IO Susan_NP1 George_NP1 were_VBDR able_JK to_TO show_VVI independently_RR that_DD1_CST MAP_NN1 kinase_NN1 activation_NN1 involves_VVZ phosphorylation_NN1 of_IO tyrosine_NN1 residues_NN2 on_II the_AT delta_NN1 and_CC mu_NN1 opioid_NN1_JJ receptors_NN2 ,_Y respectively_RR (_Y Kramer_NP1_NN1 ,_Y Andria_NP1 ,_Y Esposito_NP1_NN1 ,_Y Simon_NP1 ,_Y 2000_MC ;_Y Pak_NP1 ,_Y O'Dowd_NP1 ,_Y Wang_NP1 ,_Y George_NP1 ,_Y 1999_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  133 An understanding of signal transduction pathways could lead to very specific interference with a particular step , such as a step involved in the development of tolerance , physical dependence , or craving for drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  133 An_AT1 understanding_NN1 of_IO signal_NN1 transduction_NN1 pathways_NN2 could_VM lead_VVI to_II very_RG specific_JJ interference_NN1 with_IW a_AT1 particular_JJ step_NN1 ,_Y such_II21 as_II22 a_AT1 step_NN1 involved_JJ in_II the_AT development_NN1 of_IO tolerance_NN1 ,_Y physical_JJ dependence_NN1 ,_Y or_CC craving_VVG for_IF drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  134 <p> One dramatic example comes from the cancer field ( Schiffer , 2007 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  134 <p>_Y One_MC1 dramatic_JJ example_NN1 comes_VVZ from_II the_AT cancer_NN1 field_NN1 (_Y Schiffer_NP1 ,_Y 2007_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  135 Cancer cells in chronic myelogenous ) that is not present in exactly the same form in normal host cells .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  135 Cancer_NN1 cells_NN2 in_II chronic_JJ myelogenous_JJ )_Y that_DD1_CST is_VBZ not_XX present_JJ_NN1_VV0@ in_II_RP@ exactly_RR the_AT same_DA form_NN1 in_II normal_JJ host_NN1 cells_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  136 A drug has been developed that specifically inhibits this cancer cell enzyme with little or no effects on host cell kinases .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  136 A_AT1 drug_NN1 has_VHZ been_VBN developed_VVN that_CST_DD1 specifically_RR inhibits_VVZ this_DD1 cancer_NN1 cell_NN1 enzyme_NN1 with_IW little_JJ_DA1 or_CC no_AT effects_NN2 on_II host_NN1 cell_NN1 kinases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  137 This drug is called Gleevec and is remarkably effective in CML , with little or no side effects .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  137 This_DD1 drug_NN1 is_VBZ called_VVN Gleevec_NP1 and_CC is_VBZ remarkably_RR effective_JJ in_II CML_MC ,_Y with_IW little_JJ_DA1 or_CC no_AT side_NN1 effects_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  138 The effects on CML and some other cancers have been so dramatic that some physicians have called this treatment a cure .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  138 The_AT effects_NN2 on_II CML_MC and_CC some_DD other_JJ cancers_NN2 have_VH0 been_VBN so_RG_RR dramatic_JJ that_CST some_DD physicians_NN2 have_VH0 called_VVN this_DD1 treatment_NN1 a_AT1 cure_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  139 <p> Clearly this is the future , to try to develop highly specific treatments for all human diseases that produce minimal secondary effects because of the specificity of action .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  139 <p>_Y Clearly_RR this_DD1 is_VBZ the_AT future_NN1_JJ ,_Y to_TO try_VVI to_TO develop_VVI highly_RR specific_JJ treatments_NN2 for_IF all_DB human_JJ diseases_NN2 that_CST produce_VV0 minimal_JJ secondary_JJ_NN1 effects_NN2 because_II21 of_II22 the_AT specificity_NN1 of_IO action_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  140 Signal transduction pathways are just one of the places to look for possible targets .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  140 Signal_NN1_VV0@ transduction_NN1 pathways_NN2 are_VBR just_RR one_MC1 of_IO the_AT places_NN2 to_TO look_VVI for_IF possible_JJ targets_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  141 <p> L : WHERE WE ARE GOING With the advances discussed above , the field is moving into new areas that promise significant progress in identifying , preventing , and treating addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  141 <p>_Y L_ZZ1_NP1@ :_Y WHERE_RRQ_CS WE_PPIS2 ARE_VBR GOING_VVG With_IW the_AT advances_NN2 discussed_VVN above_RL ,_Y the_AT field_NN1 is_VBZ moving_VVG into_II new_JJ areas_NN2 that_CST promise_VV0 significant_JJ progress_NN1 in_II identifying_VVG ,_Y preventing_VVG ,_Y and_CC treating_VVG addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  142 Many key questions remain .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  142 Many_DA2 key_JJ questions_NN2 remain_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  143 What neurobiological processes ( system , cellular , and molecular ) convey vulnerability to the transition from drug use to abuse and addiction , with a particular emphasis on adolescent How do environmental and genetic factors facilitate the changes in neurobiological processes that convey vulnerability to addiction--and protection from addiction ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  143 What_DDQ neurobiological_JJ processes_NN2 (_Y system_NN1 ,_Y cellular_JJ ,_Y and_CC molecular_JJ )_Y convey_VV0 vulnerability_NN1 to_II the_AT transition_NN1 from_II drug_NN1 use_NN1_VV0 to_TO abuse_VVI and_CC addiction_NN1 ,_Y with_IW a_AT1 particular_JJ emphasis_NN1 on_II adolescent_JJ_NN1 How_RRQ do_VD0 environmental_JJ and_CC genetic_JJ factors_NN2 facilitate_VV0 the_AT changes_NN2 in_II neurobiological_JJ processes_NN2 that_CST convey_VV0 vulnerability_NN1 to_II addiction--and_CC protection_NN1 from_II addiction_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  144 How can the brain best " recover " to eliminate abuse and addiction and to eliminate relapse ( behavioral therapies , pharmacotherapies ) ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  144 How_RRQ can_VM the_AT brain_NN1 best_RRT "_Y recover_VV0 "_Y to_TO eliminate_VVI abuse_NN1 and_CC addiction_NN1 and_CC to_TO eliminate_VVI relapse_NN1 (_Y behavioral_JJ_NN1 therapies_NN2 ,_Y pharmacotherapies_NN2 )_Y ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  145 <p> Finally , while no exact marker necessarily predicts addiction , two salient changes in imaging in established and unrecovered substance-dependent individuals that cut across different drugs are decreases in orbitofrontal/prefrontal cortex function and decreases in brain dopamine D2 receptors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  145 <p>_Y Finally_RR ,_Y while_CS no_AT exact_JJ marker_NN1 necessarily_RR predicts_VVZ addiction_NN1 ,_Y two_MC salient_JJ changes_NN2 in_II imaging_VVG_NN1 in_II_RP@ established_JJ@ and_CC unrecovered_JJ substance-dependent_JJ individuals_NN2 that_CST cut_VV0_VVD@_NN1 across_II different_JJ drugs_NN2 are_VBR decreases_NN2@ in_II orbitofrontal/prefrontal_JJ_NN1 cortex_NN1 function_NN1 and_CC decreases_VVZ in_II brain_NN1 dopamine_NN1_VV0 D2_FO receptors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  146 No biochemical markers are sufficiently specific to predict a given stage of the addiction cycle , but changes in certain intermediate early genes with chronic drug exposure in animal models show promise of long-term changes in specific brain regions that may be common to all drugs of abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  146 No_XX biochemical_JJ markers_NN2 are_VBR sufficiently_RR specific_JJ to_TO predict_VVI a_AT1 given_JJ@ stage_NN1 of_IO the_AT addiction_NN1 cycle_NN1 ,_Y but_CCB changes_NN2_VVZ@ in_II certain_JJ intermediate_JJ early_JJ genes_NN2 with_IW chronic_JJ drug_NN1 exposure_NN1 in_II animal_NN1 models_NN2 show_VV0 promise_NN1 of_IO long-term_JJ changes_NN2 in_II specific_JJ brain_NN1 regions_NN2 that_CST_DD1 may_VM be_VBI common_JJ to_II all_DB drugs_NN2 of_IO abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  147 Although no biological markers of substance abuse disorders are on the immediate horizon , many promising and continually evolving biological and neurobiological aspects of substance use disorders will eventually aid in the specific diagnoses of substance use , misuse , and dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  147 Although_CS no_AT biological_JJ markers_NN2 of_IO substance_NN1 abuse_NN1 disorders_NN2 are_VBR on_II the_AT immediate_JJ horizon_NN1 ,_Y many_DA2 promising_JJ and_CC continually_RR evolving_VVG biological_JJ and_CC neurobiological_JJ aspects_NN2 of_IO substance_NN1 use_NN1_VV0 disorders_NN2 will_VM eventually_RR aid_VVI in_II the_AT specific_JJ diagnoses_NN2 of_IO substance_NN1 use_NN1_VV0 ,_Y misuse_NN1_VV0@ ,_Y and_CC dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  148 <p> Much needs to be done in the area of molecular and biochemical , as seen from this brief review .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  148 <p>_Y Much_RR_DA1 needs_VVZ to_TO be_VBI done_VDN in_II the_AT area_NN1 of_IO molecular_JJ and_CC biochemical_JJ ,_Y as_CSA seen_VVN from_II this_DD1 brief_JJ review_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  149 The big disappointment to scientists in this field is that 34 years into the modern era of drug abuse research , we still do not have a clear understanding of the cellular and molecular bases of the development and maintenance of tile phenomena of addiction , such as tolerance , physical dependence , and psychic craving .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  149 The_AT big_JJ disappointment_NN1 to_II scientists_NN2 in_II this_DD1 field_NN1 is_VBZ that_CST_RG%_DD1 34_MC years_NNT2 into_II the_AT modern_JJ era_NN1 of_IO drug_NN1 abuse_NN1 research_NN1 ,_Y we_PPIS2 still_RR do_VD0 not_XX have_VHI a_AT1 clear_JJ understanding_NN1 of_IO the_AT cellular_JJ and_CC molecular_JJ bases_NN2 of_IO the_AT development_NN1 and_CC maintenance_NN1 of_IO tile_NN1 phenomena_NN2 of_IO addiction_NN1 ,_Y such_II21 as_II22 tolerance_NN1 ,_Y physical_JJ dependence_NN1 ,_Y and_CC psychic_JJ craving_NN1@ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  150 The progress in biochemical approaches to our understanding of the enzymes involved in signal transduction pathways also has been quite impressive .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  150 The_AT progress_NN1 in_II biochemical_JJ approaches_NN2 to_II our_APPGE understanding_NN1 of_IO the_AT enzymes_NN2 involved_JJ in_II signal_NN1 transduction_NN1 pathways_NN2 also_RR has_VHZ been_VBN quite_RG impressive_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  151 Additional technologies , such as imaging and electrophysiology , which are not discussed here , have progressed rapidly as well .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  151 Additional_JJ technologies_NN2 ,_Y such_II21 as_II22 imaging_NN1_VVG and_CC electrophysiology_NN1 ,_Y which_DDQ are_VBR not_XX discussed_VVN here_RL ,_Y have_VH0 progressed_VVN rapidly_RR as_RR21_RG well_RR22_RR ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  152 We feel cautiously optimistic that the molecular basis of some of the events that lead to drug addiction and abuse will be discovered within the next 5 to 10 years .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  152 We_PPIS2 feel_VV0 cautiously_RR optimistic_JJ that_CST the_AT molecular_JJ basis_NN1 of_IO some_DD of_IO the_AT events_NN2 that_CST lead_VV0_NN1 to_II drug_NN1 addiction_NN1 and_CC abuse_NN1 will_VM be_VBI discovered_VVN@ within_II the_AT next_MD 5_MC to_II 10_MC years_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  153 What is the molecular basis of tolerance ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  153 What_DDQ is_VBZ the_AT molecular_JJ basis_NN1 of_IO tolerance_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  154 Of dependence ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  154 Of_IO dependence_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  155 What alterations in the brain cause craving for abused drugs to increase greatly , in some persons who use drugs casually and not in others ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  155 What_DDQ alterations_NN2 in_II the_AT brain_NN1 cause_NN1_VV0 craving_VVG for_IF abused_JJ@ drugs_NN2 to_TO increase_VVI greatly_RR ,_Y in_II some_DD persons_NN2 who_PNQS use_VV0 drugs_NN2 casually_RR and_CC not_XX in_II others_NN2 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  156 What is the genetic basis for these individual differences ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  156 What_DDQ is_VBZ the_AT genetic_JJ basis_NN1 for_IF these_DD2 individual_JJ differences_NN2 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  157 What is the biochemical basis Which parts of the pathways that are set into motion by the consumption of abused drugs can we intervene to block the development of addiction ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  157 What_DDQ is_VBZ the_AT biochemical_JJ basis_NN1 Which_DDQ parts_NN2 of_IO the_AT pathways_NN2 that_CST are_VBR set_VVN into_II motion_NN1 by_II the_AT consumption_NN1 of_IO abused_JJ@ drugs_NN2 can_VM we_PPIS2 intervene_VVI to_TO block_VVI the_AT development_NN1 of_IO addiction_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  158 These are some of the questions that should be answered , ' using the highly sophisticated technologies currently available .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  158 These_DD2 are_VBR some_DD of_IO the_AT questions_NN2 that_CST_DD1 should_VM be_VBI answered_VVN ,_Y '_GE_"@ using_VVG the_AT highly_RR sophisticated_JJ technologies_NN2 currently_RR available_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  159 <p> L : SUMMARY AND CONCLUSIONS The advances in the neurobiology of addiction are examined here from two domains .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  159 <p>_Y L_ZZ1_NP1@ :_Y SUMMARY_NN1 AND_CC CONCLUSIONS_NN2 The_AT advances_NN2 in_II the_AT neurobiology_NN1 of_IO addiction_NN1 are_VBR examined_VVN here_RL from_II two_MC domains_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  160 First , a heuristic framework is provided of the neurocircuitry of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  160 First_MD ,_Y a_AT1 heuristic_JJ framework_NN1 is_VBZ provided_VVN of_IO the_AT neurocircuitry_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  161 Second , advances in the molecular biology of the opioid system demonstrate the tremendous advances we have made in our understanding of the molecular basis ' of the action of the drugs of abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  161 Second_MD ,_Y advances_VVZ_NN2 in_II the_AT molecular_JJ biology_NN1 of_IO the_AT opioid_JJ_NN1 system_NN1 demonstrate_VV0 the_AT tremendous_JJ advances_NN2 we_PPIS2 have_VH0 made_VVN in_II our_APPGE understanding_NN1 of_IO the_AT molecular_JJ basis_NN1 '_GE of_IO the_AT action_NN1 of_IO the_AT drugs_NN2 of_IO abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  162 A conceptual structure for drug addiction that focuses on changes in reward system function that lead to excessive drug intake provides a framework with which to identify the neurobiological and neuroadaptive mechanisms involved in the neurobiology of drug addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  162 A_AT1_ZZ1 conceptual_JJ structure_NN1 for_IF drug_NN1 addiction_NN1 that_CST_DD1 focuses_VVZ on_II_RP@ changes_NN2 in_II reward_NN1 system_NN1 function_NN1_VV0@ that_CST_DD1 lead_VV0_NN1 to_II excessive_JJ drug_NN1 intake_NN1 provides_VVZ a_AT1 framework_NN1 with_IW which_DDQ to_TO identify_VVI the_AT neurobiological_JJ and_CC neuroadaptive_JJ mechanisms_NN2 involved_JJ in_II the_AT neurobiology_NN1 of_IO drug_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  163 The neurochemical systems implicated in the acute reinforcing effects of drugs of abuse include key elements of the basal forebrain linked by the mesocorticolimbic dopamine system , which include dopamine-dependent and -independent actions via dopamine , opioid effects of drugs of abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  163 The_AT neurochemical_JJ systems_NN2 implicated_VVD_VVN@ in_II the_AT acute_JJ reinforcing_JJ@_VVG effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 include_VV0 key_JJ elements_NN2 of_IO the_AT basal_JJ forebrain_NN1 linked_VVN by_II the_AT mesocorticolimbic_JJ dopamine_NN1 system_NN1 ,_Y which_DDQ include_VV0 dopamine-dependent_JJ and_CC -independent_JJ actions_NN2 via_II dopamine_NN1 ,_Y opioid_JJ_NN1 effects_NN2 of_IO drugs_NN2 of_IO abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  164 Neuroadaptive changes in the brain reward system during the development of dependence include decreases in these same drug reward neurochemical systems and recruitment of brain stress systems ( CRF and norepinephrine ; " dark side " ) and dysregulation of brain anti-stress systems ( NPY ) in the extended amygdala that provide the negative motivational state associated with drug abstinence ( Koob Le Moal , 2008 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  164 Neuroadaptive_JJ changes_NN2 in_II the_AT brain_NN1 reward_NN1 system_NN1 during_II the_AT development_NN1 of_IO dependence_NN1 include_VV0 decreases_NN2@_VVZ in_II these_DD2 same_DA drug_NN1 reward_NN1_VV0@ neurochemical_JJ systems_NN2 and_CC recruitment_NN1 of_IO brain_NN1 stress_NN1 systems_NN2 (_Y CRF_NP1 and_CC norepinephrine_NN1_JJ ;_Y "_Y dark_JJ_NN1 side_NN1 "_Y )_Y and_CC dysregulation_NN1 of_IO brain_NN1 anti-stress_NN1_JJ systems_NN2 (_Y NPY_NP1 )_Y in_II the_AT extended_JJ@ amygdala_NN1 that_CST provide_VV0 the_AT negative_JJ motivational_JJ state_NN1 associated_VVN with_IW drug_NN1 abstinence_NN1 (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2008_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  165 Neurochemical systems have been implicated in animal models of relapse , including dopamine , opioid peptide , and glutamate , and in drug- and cue-induced relapse in prefrontal cortical and basolateral amygdala projections to the basal forebrain .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  165 Neurochemical_JJ systems_NN2 have_VH0 been_VBN implicated_VVN@ in_II animal_NN1 models_NN2 of_IO relapse_NN1 ,_Y including_II_VVG@ dopamine_NN1 ,_Y opioid_JJ_NN1 peptide_NN1 ,_Y and_CC glutamate_NN1 ,_Y and_CC in_II drug-_NN1_JJ and_CC cue-induced_JJ_NN1 relapse_NN1 in_II prefrontal_JJ cortical_JJ and_CC basolateral_JJ_NN1 amygdala_NN1 projections_NN2 to_II the_AT basal_JJ forebrain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  166 The brain stress systems in the extended amygdala are directly implicated in stress-induced relapse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  166 The_AT brain_NN1 stress_NN1 systems_NN2 in_II the_AT extended_JJ@ amygdala_NN1 are_VBR directly_RR implicated_VVN in_II stress-induced_JJ_NN1 relapse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  167 <p> Gaps in our knowledge center on identifying the molecular changes that contribute to the neuroadaptations within specific motivationally relevant neurocircuits associated with the transition to dependence , motivational withdrawal , protracted abstinence , and vulnerability to relapse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  167 <p>_Y Gaps_NN2 in_II our_APPGE knowledge_NN1 center_NN1 on_II identifying_VVG the_AT molecular_JJ changes_NN2 that_CST contribute_VV0 to_II the_AT neuroadaptations_NN2 within_II specific_JJ motivationally_RR relevant_JJ neurocircuits_NN2 associated_VVN with_IW the_AT transition_NN1 to_II dependence_NN1 ,_Y motivational_JJ withdrawal_NN1 ,_Y protracted_JJ abstinence_NN1 ,_Y and_CC vulnerability_NN1 to_TO relapse_VVI ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  168 Nevertheless , the identification of specific neurochemical systems within specific components of the brain reward and stress systems that have an important role in solid foundation for bridging the molecular/ cellular gap .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  168 Nevertheless_RR ,_Y the_AT identification_NN1 of_IO specific_JJ neurochemical_JJ systems_NN2 within_II specific_JJ components_NN2 of_IO the_AT brain_NN1 reward_NN1 and_CC stress_NN1_VV0@ systems_NN2 that_CST have_VH0 an_AT1 important_JJ role_NN1 in_II solid_JJ foundation_NN1 for_IF bridging_VVG the_AT molecular/_JJ cellular_JJ gap_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  169 <p> L : ACKNOWLEDGEMENTS Research was supported by National Institutes of Health grants AA06420 and AA08459 from the National Institute on Alcohol Abuse and Alcoholism , DA04043 and DA04398 from the National Institute on Drug Abuse , and DK26741 from the National Institute on Diabetes and Digestive and Kidney Diseases .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  169 <p>_Y L_ZZ1_NP1@ :_Y ACKNOWLEDGEMENTS_NN2 Research_NN1 was_VBDZ supported_VVN by_II National_JJ Institutes_NN2 of_IO Health_NN1 grants_VVZ_NN2 AA06420_FO and_CC AA08459_FO from_II the_AT National_JJ Institute_NN1 on_II Alcohol_NN1 Abuse_NN1 and_CC Alcoholism_NN1 ,_Y DA04043_FO and_CC DA04398_FO from_II the_AT National_JJ Institute_NN1 on_II Drug_NN1 Abuse_NN1 ,_Y and_CC DK26741_FO from_II the_AT National_JJ Institute_NN1 on_II Diabetes_NN1 and_CC Digestive_JJ and_CC Kidney_NN1 Diseases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  170 Research also was supported by the Pearson Center for Alcoholism and Addiction Research at The Scripps Research Institute .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  170 Research_VV0@_NN1 also_RR was_VBDZ supported_VVN by_II the_AT Pearson_NP1 Center_NN1 for_IF Alcoholism_NN1 and_CC Addiction_NPX Research_NN1 at_II The_AT Scripps_NP1_NN2 Research_NN1_VV0@ Institute_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  171 Dr. Simon gratefully acknowledges the support of NIDA for over 40 years ( DA00017 ) , the former KO5 ( DA 00364 ) , which paid a portion of his salary for 5 years , as well as a Training Grant ( T32-DA07254 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  171 Dr._NNB Simon_NP1 gratefully_RR acknowledges_VVZ the_AT support_NN1 of_IO NIDA_NN1_NP1 for_IF over_RG 40_MC years_NNT2 (_Y DA00017_FO )_Y ,_Y the_AT former_DA KO5_FO (_Y DA_FU 00364_MC )_Y ,_Y which_DDQ paid_VVD a_AT1 portion_NN1 of_IO his_APPGE salary_NN1 for_IF 5_MC years_NNT2 ,_Y as_II31 well_II32 as_II33 a_AT1 Training_NN1 Grant_NP1_NN1@ (_Y T32-DA07254_NN1_JJ )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  172 He also wishes to pay tribute to the many students , postdoctoral fellows , and visiting professors he has been privileged to train and collaborate with , and whose input and hard work have been extremely important to the success of his laboratory .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  172 He_PPHS1 also_RR wishes_VVZ to_TO pay_VVI tribute_NN1 to_II the_AT many_DA2 students_NN2 ,_Y postdoctoral_JJ_NN1 fellows_NN2 ,_Y and_CC visiting_JJ_VVG professors_NN2 he_PPHS1 has_VHZ been_VBN privileged_JJ_VVN% to_TO train_VVI and_CC collaborate_VVI with_IW ,_Y and_CC whose_DDQGE input_NN1 and_CC hard_JJ_RR work_NN1 have_VH0 been_VBN extremely_RR important_JJ to_II the_AT success_NN1 of_IO his_APPGE laboratory_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  173 The authors gratefully acknowledge the editorial and research assistance of Mr. Michael A. Arends .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  173 The_AT authors_NN2 gratefully_RR acknowledge_VV0 the_AT editorial_NN1_JJ and_CC research_NN1_VV0@ assistance_NN1 of_IO Mr._NNB Michael_NP1 A._ZZ Arends_NP1_VVZ_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  174 <p> L : Table 1 Neurotransmitters Implicated in table L : Table 2 Neurotransmitters Implicated in the Motivational Effects of Withdrawal from Drugs of Abuse pre-formatted table L : Table 3 Endogenous Opioid Peptides pre-formatted table L : Table 4 List of Techniques Derived from DNA Cloning pre-formatted table DIAGRAM : Figure 1 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  174 <p>_Y L_ZZ1_NP1@ :_Y Table_NN1 1_MC1 Neurotransmitters_VVZ_NP1 Implicated_JJ_VVD@ in_II table_NN1 L_ZZ1_NP1@ :_Y Table_NN1 2_MC Neurotransmitters_NN2_NP1_VVZ Implicated_VVD@_JJ in_II the_AT Motivational_JJ Effects_NN2 of_IO Withdrawal_NN1 from_II Drugs_NN2 of_IO Abuse_NN1 pre-formatted_ZZ table_NN1 L_ZZ1_NP1@ :_Y Table_NN1 3_MC Endogenous_JJ_NP1 Opioid_JJ_NN1_NP1 Peptides_NN2 pre-formatted_ZZ table_NN1 L_ZZ1_NP1@ :_Y Table_NN1 4_MC List_NN1 of_IO Techniques_NN2 Derived_VVN from_II DNA_NN1 Cloning_NN1_VVG@ pre-formatted_ZZ table_NN1 DIAGRAM_NN1 :_Y Figure_NN1_VV0% 1_MC1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  175 Diagram describing the addiction **33;5888;TOOLONG , binge/intoxication , and withdrawal/negative affect--from a psychiatric perspective with the different criteria for substance dependence incorporated from the DSM-IV .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  175 Diagram_NN1 describing_VVG the_AT addiction_NN1 **33;5888;TOOLONG_FO ,_Y binge/intoxication_NN1 ,_Y and_CC withdrawal/negative_NN1 affect--from_II a_AT1 psychiatric_JJ perspective_NN1 with_IW the_AT different_JJ criteria_NN2 for_IF substance_NN1 dependence_NN1 incorporated_VVN from_II the_AT DSM-IV_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  176 <p> DIAGRAM : Figure 2 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  176 <p>_Y DIAGRAM_NN1 :_Y Figure_NN1 2_MC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  177 Early neurocircuitry diagram of drug reward for opiates ( Wise , 1980 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  177 Early_JJ neurocircuitry_NN1 diagram_NN1 of_IO drug_NN1 reward_NN1 for_IF opiates_NN2 (_Y Wise_NP1 ,_Y 1980_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  178 " Suggested sites of potential interaction of opiates with brain reward circuitry .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  178 "_Y Suggested_JJ@_VVN sites_NN2 of_IO potential_JJ_NN1 interaction_NN1 of_IO opiates_NN2 with_IW brain_NN1 reward_NN1 circuitry_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  179 Opiate receptor fields are shaded in the region of the striatal dopamine terminal field , the tegmental dopamine cell region , and the region of the locus coeruleus , which is thought to inhibit reward circuitry , perhaps by an inhibitory synapse on the dopamine cells themselves .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  179 Opiate_VV0_NN1 receptor_NN1 fields_NN2 are_VBR shaded_VVN@_JJ in_II the_AT region_NN1 of_IO the_AT striatal_JJ dopamine_NN1 terminal_NN1_JJ field_NN1 ,_Y the_AT tegmental_JJ dopamine_NN1 cell_NN1 region_NN1 ,_Y and_CC the_AT region_NN1 of_IO the_AT locus_NN1 coeruleus_NN ,_Y which_DDQ is_VBZ thought_VVN to_TO inhibit_VVI reward_NN1 circuitry_NN1 ,_Y perhaps_RR by_II an_AT1 inhibitory_JJ synapse_NN1 on_II the_AT dopamine_NN1 cells_NN2 themselves_PPX2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  180 Opiates inhibit locus coeruleus firing ; their actions in the tegmentum and striatum are not yet understood , and may be either pre- or post-synaptic in either region .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  180 Opiates_NN2_NP1@ inhibit_VV0_NN1 locus_NN1 coeruleus_NN firing_VVG_NN1 ;_Y their_APPGE actions_NN2 in_II the_AT tegmentum_NN1 and_CC striatum_NN1 are_VBR not_XX yet_RR understood_VVN_VVD ,_Y and_CC may_VM be_VBI either_RR pre-_JJ or_CC post-synaptic_JJ_NN1@ in_II either_DD1 region_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  181 Thus , opiates may act on , or either reward function .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  181 Thus_RR ,_Y opiates_NN2_VVZ may_VM act_VVI on_RP@ ,_Y or_CC either_RR reward_NN1 function_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  182 " Taken with permission from Wise , 1980 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  182 "_Y Taken_VVN with_IW permission_NN1 from_II Wise_NP1_JJ ,_Y 1980_MC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  183 <p> L : REFERENCES -- Evans , C. , Keith , D. , Morrison , H. , Magendzo , K. , Edwards , R. 1992 Cloning of a delta-opioid receptor by functional expression .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  183 <p>_Y L_ZZ1_NP1@ :_Y REFERENCES_NN2_VVZ@ --_ZZ Evans_NP1 ,_Y C._NP1_ZZ1@ ,_Y Keith_NP1 ,_Y D._NP1 ,_Y Morrison_NP1 ,_Y H._NP1 ,_Y Magendzo_NP1_NN1 ,_Y K._NP1 ,_Y Edwards_NP1 ,_Y R._NP1 1992_MC Cloning_NN1 of_IO a_AT1 delta-opioid_JJ_NN1 receptor_NN1 by_II functional_JJ expression_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  184 Science , 258 , 1952-1955 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  184 Science_NN1 ,_Y 258_MC ,_Y 1952-1955_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  185 <p> -- Gioannini , T.L. , Fan , L.Q. , Hyde , L. , Ofri , D. , Yao , Y. , Hiller , J.M. , Simon , E.J. 1993 Reconstitution of a purified mu-opioid binding protein in liposomes : Selective , high affinity , GTP-gamma S-sensitive mu-opioid agonist binding is restored .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  185 <p>_Y --_ZZ Gioannini_NN1_NP1_NN2@ ,_Y T.L._NP1 ,_Y Fan_VV0_NN1 ,_Y L.Q._NP1 ,_Y Hyde_NP1 ,_Y L._NP1 ,_Y Ofri_NP1_NN1 ,_Y D._NP1 ,_Y Yao_NP1 ,_Y Y._NP1 ,_Y Hiller_NN1_NP1@ ,_Y J.M._NP1 ,_Y Simon_NP1 ,_Y E.J._NP1 1993_MC Reconstitution_NN1 of_IO a_AT1 purified_JJ@ mu-opioid_JJ_NN1 binding_JJ_VVG protein_NN1 in_II liposomes_NN2 :_Y Selective_JJ ,_Y high_JJ affinity_NN1 ,_Y GTP-gamma_JJ S-sensitive_JJ mu-opioid_JJ_NN1 agonist_NN1 binding_NN1@_VVG is_VBZ restored_VVN_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  186 Biochemical and Biophysical Research Communications , 194 , 901-908 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  186 Biochemical_JJ_NP1@ and_CC Biophysical_JJ_NP1 Research_NN1 Communications_NN2 ,_Y 194_MC ,_Y 901-908_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  187 <p> -- Gioannini , T.L. , Howard , A.D. , Hiller , J.M. , Simon , E.J. 1985 Purification of an active opioid binding protein from bovine striatum .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  187 <p>_Y --_ZZ Gioannini_NN1_NP1_NN2@ ,_Y T.L._NP1 ,_Y Howard_NP1 ,_Y A.D._RA ,_Y Hiller_NN1_NP1@ ,_Y J.M._NP1 ,_Y Simon_NP1 ,_Y E.J._NP1 1985_MC Purification_NN1 of_IO an_AT1 active_JJ opioid_JJ_NN1 binding_JJ_VVG protein_NN1 from_II bovine_JJ striatum_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  188 Journal of Biological Chemistry , 260 , 15117-15121 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  188 Journal_NN1 of_IO Biological_JJ Chemistry_NN1 ,_Y 260_MC ,_Y 15117-15121_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  189 <p> -- Heilig , M. , Koob , G.F. , Ekman , R. , Britton , K.T. 1994 Corticotropin-releasing factor and neuropeptide Y : Role in emotional integration .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  189 <p>_Y --_ZZ Heilig_NN1_NP1 ,_Y M._NN1 ,_Y Koob_NP1 ,_Y G.F._NP1 ,_Y Ekman_NP1_NN1 ,_Y R._NP1 ,_Y Britton_NP1 ,_Y K.T._NP1 1994_MC Corticotropin-releasing_JJ factor_NN1 and_CC neuropeptide_VV0_NN1 Y_ZZ1 :_Y Role_NN1 in_II emotional_JJ integration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  190 Trends in Neurosciences , 17 Koob , G.F. 2004 Corticotropin-releasing factor in brain : A role in activation , arousal , and affect regulation .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  190 Trends_NN2 in_II Neurosciences_NP2_NN2@ ,_Y 17_MC Koob_NP1 ,_Y G.F._NP1 2004_MC Corticotropin-releasing_JJ factor_NN1 in_II brain_NN1 :_Y A_AT1@_ZZ1 role_NN1 in_II activation_NN1 ,_Y arousal_NN1 ,_Y and_CC affect_VV0_NN1 regulation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  191 Journal of Pharmacology and Experimental Therapeutics , 311,427-440 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  191 Journal_NN1 of_IO Pharmacology_NP1_NN1 and_CC Experimental_JJ Therapeutics_NN1 ,_Y 311,427-440_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  192 <p> -- Kieffer , B. , Befort , K. , Ruff , C. , Hirth , C. 1992 The delta-opioid receptor : Isolation of a cDNA by expression cloning and pharmacological characterization .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  192 <p>_Y --_ZZ Kieffer_NN1_NP1 ,_Y B._NP1 ,_Y Befort_NP1_VV0_NN1 ,_Y K._NP1 ,_Y Ruff_NN1 ,_Y C._NP1_ZZ1@ ,_Y Hirth_NP1_NN1 ,_Y C._NP1_ZZ1@ 1992_MC The_AT delta-opioid_JJ_NN1 receptor_NN1 :_Y Isolation_NN1 of_IO a_AT1 cDNA_NN1 by_II expression_NN1 cloning_NN1 and_CC pharmacological_JJ characterization_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  193 Proceedings of the National Academy of Sciences USA , 89 , 12048-12052 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  193 Proceedings_NN2 of_IO the_AT National_JJ Academy_NN1 of_IO Sciences_NN2 USA_NP1 ,_Y 89_MC ,_Y 12048-12052_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  194 <p> -- Kieffer , B. , Gaveriaux-Ruff , C. 2002 Exploring the opioid system by gene knockout .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  194 <p>_Y --_ZZ Kieffer_NN1_NP1 ,_Y B._NP1 ,_Y Gaveriaux-Ruff_NP1 ,_Y C._NP1_ZZ1@ 2002_MC Exploring_VVG the_AT opioid_JJ_NN1 system_NN1 by_II gene_NN1 knockout_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  195 Progress in Neurobiology , 66 , 285-306 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  195 Progress_NN1_VV0@ in_II Neurobiology_NP1_NN1 ,_Y 66_MC ,_Y 285-306_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  196 <p> -- Koob , G.F. 1992 Drugs of abuse : Anatomy , pharmacology , and function of reward pathways .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  196 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 1992_MC Drugs_NN2 of_IO abuse_NN1 :_Y Anatomy_NN1 ,_Y pharmacology_NN1 ,_Y and_CC function_NN1 of_IO reward_NN1 pathways_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  197 Trends in Pharmacological Sciences , 13 , 177-184 <p> -- Koob , G.F. 2003 Neuroadaptive mechanisms of addiction : Studies on the extended amygdala .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  197 Trends_NN2 in_II Pharmacological_JJ_NP1 Sciences_NN2 ,_Y 13_MC ,_Y 177-184_MCMC <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 2003_MC Neuroadaptive_JJ mechanisms_NN2 of_IO addiction_NN1 :_Y Studies_NN2 on_II the_AT extended_JJ@ amygdala_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  198 European Neuropsychopharmacology , 13 , 442-452 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  198 European_JJ Neuropsychopharmacology_NN1_NP1 ,_Y 13_MC ,_Y 442-452_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  199 <p> -- Koob , G.F. 2004 Allostatic view of motivation : Implications for psychopathology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  199 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 2004_MC Allostatic_JJ view_NN1 of_IO motivation_NN1 :_Y Implications_NN2 for_IF psychopathology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  200 In R.A. Bevins M.T .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  200 In_II R.A._NP1 Bevins_NP1 M.T_NNL1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  201 Bardo ( Eds .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  201 Bardo_NP1@_NN1 (_Y Eds_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  202 ) , Motivational factors in the etiology of drug abuse ( ) ( pp. 1-18 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  202 )_Y ,_Y Motivational_JJ factors_NN2 in_II the_AT etiology_NN1 of_IO drug_NN1 abuse_NN1 (_Y )_Y (_Y pp._NNU2 1-18_MCMC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  203 Lincoln NE : University of Nebraska Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  203 Lincoln_NP1 NE_ND1 :_Y University_NN1 of_IO Nebraska_NP1 Press_NN1_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  204 <p> -- Koob , G.F. 2008 A role for brain stress systems in addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  204 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 2008_MC A_ZZ1_AT1@ role_NN1 for_IF brain_NN1 stress_NN1 systems_NN2 in_II addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  205 Neuron , 59 , 11-34 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  205 Neuron_NN1_NP1@ ,_Y 59_MC ,_Y 11-34_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  206 <p> -- Koob , G.F. , Le Moal , M. 2001 Drug addiction , dysregulation of reward , and allostasis .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  206 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 ,_Y Le_NP1 Moal_NP1 ,_Y M._NN1 2001_MC Drug_NN1 addiction_NN1 ,_Y dysregulation_NN1 of_IO reward_NN1 ,_Y and_CC allostasis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  207 Neuropsychopharmacology , 24 , 97-129 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  207 Neuropsychopharmacology_NN1_NP1@ ,_Y 24_MC ,_Y 97-129_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  208 <p> -- Koob , G.F. , Le Moal , M. 2005 Plasticity of reward neurocircuitry and the ' dark side ' of drug addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  208 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 ,_Y Le_NP1 Moal_NP1 ,_Y M._NN1 2005_MC Plasticity_NN1 of_IO reward_NN1 neurocircuitry_NN1 and_CC the_AT '_GE dark_JJ_NN1 side_NN1 '_GE of_IO drug_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  209 Nature Neuroscience , 8 , 1442-1444 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  209 Nature_NN1 Neuroscience_NP1_NN1@ ,_Y 8_MC ,_Y 1442-1444_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  210 <p> -- Koob , G.F. , Le Moal , M. 2006 Neurobiology of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  210 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 ,_Y Le_NP1 Moal_NP1 ,_Y M._NN1 2006_MC Neurobiology_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  211 London : Academic Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  211 London_NP1 :_Y Academic_JJ Press_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  212 <p> -- Koob , G.F. , Le Moal , M. 2008 Addiction and the brain antireward system .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  212 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 ,_Y Le_NP1 Moal_NP1 ,_Y M._NN1 2008_MC Addiction_NPX and_CC the_AT brain_NN1 antireward_JJ system_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  213 Annual Review of Psychology , 59 , 29-53 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  213 Annual_JJ Review_NN1 of_IO Psychology_NN1 ,_Y 59_MC ,_Y 29-53_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  214 <p> -- Koob , G.F. , Sanna , P.P. , Bloom , F.E. 1998 Neuroscience of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  214 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 ,_Y Sanna_NP1 ,_Y P.P._NN1 ,_Y Bloom_NP1 ,_Y F.E._FO 1998_MC Neuroscience_NN1@_NP1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  215 Neuron , 21,467-476 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  215 Neuron_NN1_NP1@ ,_Y 21,467-476_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  216 <p> -- Kramer , H.K. , Andria , M.L. , Esposito , D.H. , Simon , E.J. 2000 Tyrosine phosphorylation of the kinase activation and receptor internalization .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  216 <p>_Y --_ZZ Kramer_NN1_NP1 ,_Y H.K._NP1 ,_Y Andria_NP1 ,_Y M.L._NNU ,_Y Esposito_NP1_NN1 ,_Y D.H._NP1 ,_Y Simon_NP1 ,_Y E.J._NP1 2000_MC Tyrosine_NP1 phosphorylation_NN1 of_IO the_AT kinase_NN1 activation_NN1 and_CC receptor_NN1 internalization_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  217 Biochemical Pharmacology , 60 , 781-792 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  217 Biochemical_JJ_NP1@ Pharmacology_NN1_NP1 ,_Y 60_MC ,_Y 781-792_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  218 <p> -- McFarland , K. , Kalivas , P.W .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  218 <p>_Y --_ZZ McFarland_NP1 ,_Y K._NP1 ,_Y Kalivas_NP2_NN2@ ,_Y P.W_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  219 2001 The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  219 2001_MC The_AT circuitry_NN1 mediating_VVG cocaine-induced_JJ_NN1 reinstatement_NN1 of_IO drug-seeking_JJ_NN1 behavior_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  220 Journal of Neuroscience , 21 , 8655-8663 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  220 Journal_NN1 of_IO Neuroscience_NP1 ,_Y 21_MC ,_Y 8655-8663_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  221 <p> -- Noda , M. , Teranishi , Y. , Takahashi , H. , Toyosato , M. , Notake , M. , Nakanishi , S. , Numa , S. 1982 Isolation and structural organization of the human preproenkephalin gene .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  221 <p>_Y --_ZZ Noda_NP1_NN1@ ,_Y M._NN1 ,_Y Teranishi_NP1_NN1 ,_Y Y._NP1 ,_Y Takahashi_NP1_NN1 ,_Y H._NP1 ,_Y Toyosato_NP1_NN1 ,_Y M._NN1 ,_Y Notake_NP1 ,_Y M._NN1 ,_Y Nakanishi_NP1_NN1 ,_Y S._NP1 ,_Y Numa_NP1 ,_Y S._NP1 1982_MC Isolation_NN1 and_CC structural_JJ organization_NN1 of_IO the_AT human_JJ_NN1 preproenkephalin_NN1 gene_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  222 Nature , 297 , 431-434 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  222 Nature_NN1 ,_Y 297_MC ,_Y 431-434_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  223 <p> -- Pak , Y. , O'Dowd , B.F. , Wang , J.B. , George , S.R. 1999 Agonist-induced , G protein-dependent and -independent down-regulation of the mu opioid receptor .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  223 <p>_Y --_ZZ Pak_NP1_NN1@ ,_Y Y._NP1 ,_Y O'Dowd_NP1 ,_Y B.F._NP1 ,_Y Wang_NP1 ,_Y J.B._NP1 ,_Y George_NP1 ,_Y S.R._NNA 1999_MC Agonist-induced_JJ_NN1 ,_Y G_ZZ1 protein-dependent_JJ and_CC -independent_JJ down-regulation_NN1 of_IO the_AT mu_NN1 opioid_NN1_JJ receptor_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  224 The receptor is a direct substrate for protein tyrosine kinase .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  224 The_AT receptor_NN1 is_VBZ a_AT1 direct_JJ substrate_NN1 for_IF protein_NN1 tyrosine_NN1_VV0 kinase_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  225 Journal of Biological Chemistry , 2 74 , 27610-27616 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  225 Journal_NN1 of_IO Biological_JJ Chemistry_NN1 ,_Y 2_MC 74_MC ,_Y 27610-27616_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  226 <p> -- Pert , C.B. , Snyder , S.H .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  226 <p>_Y --_ZZ Pert_JJ ,_Y C.B._NP1 ,_Y Snyder_NP1_VV0_NN1 ,_Y S.H_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  227 1973 Opiate receptor : Demonstration in nervous tissue .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  227 1973_MC Opiate_NP1_NN1_VV0 receptor_NN1 :_Y Demonstration_NN1 in_II nervous_JJ tissue_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  228 Science , 179 , 1011-1014 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  228 Science_NN1 ,_Y 179_MC ,_Y 1011-1014_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  229 <p> -- Schiffer , C.A. 2007 BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  229 <p>_Y --_ZZ Schiffer_NP1 ,_Y C.A._NP1 2007_MC BCR-ABL_JJ tyrosine_NN1 kinase_NN1 inhibitors_NN2 for_IF chronic_JJ myelogenous_JJ leukemia_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  230 New England Journal of Medicine , 357 , U. , Lu , L. , De Wit , H. , Stewart , J. 2003 The reinstatement model of drug relapse : History , methodology and major findings .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  230 New_NP1 England_NP1 Journal_NN1 of_IO Medicine_NN1 ,_Y 357_MC ,_Y U._NP1 ,_Y Lu_NP1_NN1 ,_Y L._NP1 ,_Y De_NP1 Wit_NN1 ,_Y H._NP1 ,_Y Stewart_NP1 ,_Y J._NP1 2003_MC The_AT reinstatement_NN1 model_NN1 of_IO drug_NN1 relapse_NN1_VV0 :_Y History_NN1 ,_Y methodology_NN1 and_CC major_JJ findings_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  231 Psychopharmacology , 168 , 3-20 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  231 Psychopharmacology_NN1_NP1@ ,_Y 168_MC ,_Y 3-20_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  232 <p> -- Shippenberg , T.S. , Koob , G.F. 2002 Recent advances in animal models of drug addiction and alcoholism .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  232 <p>_Y --_ZZ Shippenberg_NP1 ,_Y T.S._NP2 ,_Y Koob_NP1 ,_Y G.F._NP1 2002_MC Recent_JJ advances_NN2 in_II animal_NN1 models_NN2 of_IO drug_NN1 addiction_NN1 and_CC alcoholism_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  233 In K.L. Davis , D. Charney , J.T. Coyle , C. Nemeroff , ( Eds .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  233 In_II K.L._NP1 Davis_NP1 ,_Y D._NP1 Charney_NP1 ,_Y J.T._NP1 Coyle_NP1 ,_Y C._NP1 Nemeroff_NP1 ,_Y (_Y Eds_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  234 ) , Neuropsychopharmacology : The fifth generation of progress ( pp. 1381 - 1397 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  234 )_Y ,_Y Neuropsychopharmacology_NP1@_NN1 :_Y The_AT fifth_MD generation_NN1 of_IO progress_NN1 (_Y pp._NNU2 1381_MC -_- 1397_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  235 Philadelphia : Lippincott Williams and Wilkins .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  235 Philadelphia_NP1 :_Y Lippincott_NP1 Williams_NP1 and_CC Wilkins_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  236 <p> -- Simon , E.J. , Hiller , J.M. 1994 Opioid peptides and opioid receptors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  236 <p>_Y --_ZZ Simon_NP1 ,_Y E.J._NP1 ,_Y Hiller_NN1_NP1@ ,_Y J.M._NP1 1994_MC Opioid_JJ peptides_NN2 and_CC opioid_JJ_NN1 receptors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  237 In G. J. E. A. Siegel , ( Eds .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  237 In_II G._NP1 J._NP1 E._NP1 A._ZZ Siegel_NP1 ,_Y (_Y Eds_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  238 ) , Basic neurochemistry : Molecular , cellular , and medical aspects ( pp. 32i-339 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  238 )_Y ,_Y Basic_JJ neurochemistry_NN1 :_Y Molecular_JJ ,_Y cellular_JJ ,_Y and_CC medical_JJ aspects_NN2 (_Y pp._NNU2 32i-339_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  239 New York : Raven Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  239 New_NP1 York_NP1 :_Y Raven_JJ_NP1 Press_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  240 <p> -- Simon , E.J. , Hiller , J.M. , Edelman , 1 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  240 <p>_Y --_ZZ Simon_NP1 ,_Y E.J._NP1 ,_Y Hiller_NN1_NP1@ ,_Y J.M._NP1 ,_Y Edelman_NP1_NN1 ,_Y 1_MC1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  241 1973 Stereospecific binding of the potent narcotic analgesic 3Hetorphine to rat brain homogenate .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  241 1973_MC Stereospecific_JJ binding_NN1@_JJ of_IO the_AT potent_JJ narcotic_NN1 analgesic_NN1 3Hetorphine_FO to_II rat_NN1 brain_NN1 homogenate_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  242 Proceedings of the National Academy of Sciences USA , 70 , 1947-1949 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  242 Proceedings_NN2 of_IO the_AT National_JJ Academy_NN1 of_IO Sciences_NN2 USA_NP1 ,_Y 70_MC ,_Y 1947-1949_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  243 <p> and a synaptic plasma membrane fraction of rat cerebral cortex .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  243 <p>_Y and_CC a_AT1 synaptic_JJ plasma_NN1 membrane_NN1 fraction_NN1 of_IO rat_NN1 cerebral_JJ cortex_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  244 Acta Pharmacoligica Toxicoligica , 32 , 317-320 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  244 Acta_NP1@ Pharmacoligica_NP1 Toxicoligica_NP1 ,_Y 32_MC ,_Y 317-320_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  245 <p> -- Volkow , N.D. , Fowler , J.S. 2000 Addiction , a disease of compulsion and drive : Involvement of the orbitofrontal cortex .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  245 <p>_Y --_ZZ Volkow_NN1_NP1 ,_Y N.D._NP1 ,_Y Fowler_NP1 ,_Y J.S._NP2 2000_MC Addiction_NPX ,_Y a_AT1 disease_NN1 of_IO compulsion_NN1 and_CC drive_VV0_NN1 :_Y Involvement_NN1 of_IO the_AT orbitofrontal_JJ cortex_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  246 Cerebral Cortex , 10 , 318-325 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  246 Cerebral_JJ Cortex_NN1 ,_Y 10_MC ,_Y 318-325_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  247 <p> -- Volkow , N.D. , Li , T.K. 2004 Drug addiction : The neurobiology of behavior gone awry .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  247 <p>_Y --_ZZ Volkow_NN1_NP1 ,_Y N.D._NP1 ,_Y Li_NP1 ,_Y T.K._NP1 2004_MC Drug_NN1 addiction_NN1 :_Y The_AT neurobiology_NN1 of_IO behavior_NN1 gone_VVN awry_RL ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  248 Nature Reviews Neuroscience , 5 , 963-970 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  248 Nature_NN1 Reviews_VVZ Neuroscience_NP1 ,_Y 5_MC ,_Y 963-970_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  249 <p> -- Wise , R.A. 1980 Action of drugs of abuse on brain reward systems .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  249 <p>_Y --_ZZ Wise_NP1 ,_Y R.A._NNA 1980_MC Action_NN1 of_IO drugs_NN2 of_IO abuse_NN1 on_II brain_NN1 reward_NN1 systems_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  250 Pharmacology Biochemistry and Behavior , 13 ( Suppl 1 ) , 213-223 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  250 Pharmacology_NP1@_NN1 Biochemistry_NP1_NN1 and_CC Behavior_NP1_NN1 ,_Y 13_MC (_Y Suppl_VV0_NP1_NN1 1_MC1 )_Y ,_Y 213-223_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  251 <p> By George F. Kooe and Eric J. Simon <p> George F. Koob , Ph.D. , is Professor and Chairman of the Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute and Adjunct Professor in the Departments of Psychology and Psychiatry and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California , San Diego .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  251 <p>_Y By_II George_NP1 F._NP1 Kooe_NP1 and_CC Eric_NP1 J._NP1 Simon_NP1 <p>_Y George_NP1 F._NP1 Koob_NP1 ,_Y Ph.D._NNA ,_Y is_VBZ Professor_NN1 and_CC Chairman_NN1 of_IO the_AT Committee_NN1 on_II the_AT Neurobiology_NN1 of_IO Addictive_JJ Disorders_NN2 at_II The_AT Scripps_NP1_NN2 Research_NN1_VV0@ Institute_NN1 and_CC Adjunct_NN1 Professor_NN1 in_II the_AT Departments_NN2 of_IO Psychology_NN1 and_CC Psychiatry_NP1_NN1 and_CC the_AT Skaggs_NP1 School_NN1 of_IO Pharmacy_NP1_NN1 and_CC Pharmaceutical_JJ Sciences_NN2 at_II the_AT University_NN1 of_IO California_NP1 ,_Y San_NP1 Diego_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  252 He specializes on the neurobiology and theoretical constructs of drug addiction , reward , and stress .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  252 He_PPHS1 specializes_VVZ on_II the_AT neurobiology_NN1 and_CC theoretical_JJ constructs_NN2 of_IO drug_NN1 addiction_NN1 ,_Y reward_NN1_VV0@ ,_Y and_CC stress_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  253 <p> Dr. New York University Medical Center .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  253 <p>_Y Dr._NNB New_NP1 York_NP1 University_NN1 Medical_JJ Center_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  254 Dr. Simon 's laboratory has done pioneering research on the mode of action of narcotic analgesics .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  254 Dr._NNB Simon_NP1 's_GE laboratory_NN1 has_VHZ done_VDN pioneering_JJ research_NN1 on_II the_AT mode_NN1 of_IO action_NN1 of_IO narcotic_NN1 analgesics_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  255 In 1973 his laboratory , and others , discovered the opiate receptors in the brain .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  255 In_II 1973_MC his_APPGE laboratory_NN1 ,_Y and_CC others_NN2 ,_Y discovered_VVD the_AT opiate_NN1 receptors_NN2 in_II the_AT brain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  256 He and his collaborators have continued to work on opiate receptors and endogenous opioid peptides and have published 250 papers in excellent journals .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  256 He_PPHS1 and_CC his_APPGE collaborators_NN2 have_VH0 continued_VVN to_TO@_II work_VVI_NN1 on_II opiate_NN1 receptors_NN2 and_CC endogenous_JJ opioid_JJ_NN1 peptides_NN2 and_CC have_VH0 published_VVN 250_MC papers_NN2 in_II excellent_JJ journals_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  257 He coined the widely used term " endorphins .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  257 He_PPHS1 coined_VVD the_AT widely_RR used_JJ_VVN term_NN1 "_Y endorphins_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  A    0  258 " <p>
SENTPOS COCA_acad_wlp_2009_01_FILE##4070857 COCA  B    0  258 "_Y <p>_Y
